VOXX International (VOXX) 10-Q10 Oct 242025 Q2 Quarterly reportFinancial data

Company Profile

Document and Entity Information

Document and Entity Information Document - shares	6 Months Ended
Document and Entity Information Document - shares	Aug. 31, 2024	Oct. 08, 2024
Document Information [Line Items]
Entity Registrant Name	VOXX International Corporation
Title of 12(b) Security	Class A Common Stock $.01 par value
Entity Trading Symbol	VOXX
Security Exchange Name	NASDAQ
Entity Central Index Key	0000807707
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Current Fiscal Year End Date	--02-28
Entity Filer Category	Accelerated Filer
Document Type	10-Q
Document Period End Date	Aug. 31, 2024
Document Fiscal Year Focus	2025
Document Fiscal Period Focus	Q2
Amendment Flag	false
Entity Shell Company	false
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Address, State or Province	FL
Entity File Number	0-28839
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	13-1964841
Entity Address, Address Line One	2351 J Lawson Blvd
Entity Address, City or Town	Orlando
Entity Address, Postal Zip Code	32824
City Area Code	800
Local Phone Number	645-7750
Document Quarterly Report	true
Document Transition Report	false
Class A Common Stock [Member]
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		20,244,217
Class B Common Stock [Member]
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		2,260,954

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($) $ in Thousands	Aug. 31, 2024	Feb. 29, 2024
Current assets:
Cash and cash equivalents	$ 3,661	$ 10,986
Accounts receivable, net of allowances of $1,980 and $3,041 at August 31, 2024 and February 29, 2024, respectively	64,240	71,066
Inventory	113,253	128,471
Receivables from vendors	795	1,192
Prepaid expenses and other current assets	15,743	20,820
Income tax receivable	4,710	2,095
Total current assets	226,944	235,868
Investment securities	398	828
Equity investments	22,848	21,380
Property, plant and equipment, net	44,201	45,070
Operating lease, right of use assets	2,815	2,577
Goodwill	64,344	63,931
Intangible assets, net	56,632	68,766
Due from GalvanEyes LLC, less current portion (Note 22)	$ 0	$ 1,340
Other Receivable, after Allowance for Credit Loss, Noncurrent, Related Party, Type [Extensible Enumeration]	us-gaap:RelatedPartyMember	us-gaap:RelatedPartyMember
Deferred income tax assets	$ 60	$ 1,452
Other assets	2,922	2,794
Total assets	421,164	444,006
Current liabilities:
Accounts payable	43,895	35,076
Accrued expenses and other current liabilities	38,397	38,238
Income taxes payable	1,168	1,123
Accrued sales incentives	16,810	18,236
Contract liabilities, current	3,265	3,810
Current portion of long-term debt	4,469	500
Total current liabilities	108,004	96,983
Long-term debt, net of debt issuance costs	50,015	71,881
Finance lease liabilities, less current portion	484	644
Operating lease liabilities, less current portion	1,917	1,884
Deferred compensation	398	828
Deferred income tax liabilities	2,615	2,690
Other tax liabilities	721	809
Prepaid ownership interest in EyeLock LLC due to GalvanEyes LLC (Note 22)	0	9,817
Other long-term liabilities	2,850	2,170
Total liabilities	167,004	187,706
Commitments and contingencies (Note 25)
Redeemable equity: Class A, $.01 par value; 597,021 and 577,581 shares at August 31, 2024 and February 29, 2024, respectively (Note 9)	4,173	4,110
Redeemable non-controlling interest (Note 3)	(4,041)	(3,203)
Stockholders' equity:
Preferred stock:
Paid-in capital	295,959	293,272
Retained earnings	51,415	58,272
Accumulated other comprehensive loss	(17,219)	(17,366)
Less: Treasury stock, at cost, 4,351,183 and 4,287,041 shares of Class A Common Stock at August 31, 2024 and February 29, 2024, respectively	(39,821)	(39,573)
Total VOXX International Corporation stockholders' equity	290,596	294,867
Non-controlling interest	(36,568)	(39,474)
Total stockholders' equity	254,028	255,393
Total liabilities, redeemable equity, redeemable non-controlling interest, and stockholders' equity	421,164	444,006
Established Inc [Member]
Current assets:
Due from other receivables	24,542	0
GalvanEyes LLC [Member]
Current assets:
Due from other receivables	0	1,238
Common Class A [Member]
Stockholders' equity:
Common stock	240	240
Common Class B [Member]
Stockholders' equity:
Common stock	$ 22	$ 22

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Thousands	Aug. 31, 2024	Feb. 29, 2024
Accounts receivable, allowances	$ 1,980	$ 3,041
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Treasury stock, shares	4,351,183	4,287,041
Common Class A [Member]
Redeemable equity par value	$ 0.01	$ 0.01
Redeemable equity shares outstanding	597,021	577,581
Common Stock, Par or Stated Value Per Share	$ 0.01	$ 0.01
Common Stock, Shares Authorized	60,000,000	60,000,000
Common stock, shares issued	23,998,379	23,985,603
Common stock, shares outstanding	19,647,196	19,698,562
Treasury stock, shares	4,351,183	4,287,041
Common Class B [Member]
Common Stock, Par or Stated Value Per Share	$ 0.01	$ 0.01
Common Stock, Shares Authorized	10,000,000	10,000,000
Common stock, shares issued	2,260,954	2,260,954
Common stock, shares outstanding	2,260,954	2,260,954

Consolidated Statements of Oper

Consolidated Statements of Operations and Comprehensive Income (Loss) (Unaudited) - USD ($) $ in Thousands	3 Months Ended			6 Months Ended
	Aug. 31, 2024		Aug. 31, 2023	Aug. 31, 2024		Aug. 31, 2023
Income Statement [Abstract]
Net sales	$ 92,488		$ 113,642	$ 184,149		$ 225,568
Cost of sales	69,796		85,017	136,048		169,363
Gross profit	22,692		28,625	48,101		56,205
Operating expenses:
Selling	7,848		10,021	17,438		21,187
General and administrative	15,777		17,250	32,234		36,677
Engineering and technical support	6,100		7,857	12,344		16,194
Restructuring expenses	2,098		2,008	2,329		2,067
Total operating expenses	31,823		37,136	64,345		76,125
Operating loss	(9,131)		(8,511)	(16,244)		(19,920)
Other income (expense) :
Interest and bank charges	(1,973)		(1,573)	(4,111)		(3,119)
Equity in income of equity investees	200	[1]	1,241	551	[1]	2,857
Gain on sale of business	8,300		0	8,300		0
Gain on sale of assets	2,154		0	2,154		0
Final arbitration award	0		(1,612)	0		(2,598)
Other, net	3,842		(952)	1,971		(1,653)
Total other income (expense), net	12,523		(2,896)	8,865		(4,513)
Income (loss) before income taxes	3,392	[1],[2]	(11,407)	(7,379)	[1],[2]	(24,433)
Income tax expense (benefit)	1,600		1,170	1,006		(151)
Net income (loss)	1,792		(12,577)	(8,385)		(24,282)
Less: net loss attributable to non-controlling interest	(620)		(1,513)	(1,528)		(2,480)
Net income (loss) attributable to VOXX International Corporation and Subsidiaries	2,412		(11,064)	(6,857)		(21,802)
Other comprehensive (loss) income:
Foreign currency translation adjustments	(337)		820	258		1,058
Derivatives designated for hedging	(90)		34	(103)		(26)
Pension plan adjustments	(8)		(5)	(8)		(6)
Other comprehensive (loss) income, net of tax	(435)		849	147		1,026
Comprehensive income (loss) attributable to VOXX International Corporation and Subsidiaries	$ 1,977		$ (10,215)	$ (6,710)		$ (20,776)
Income (loss) per share - basic: Attributable to VOXX International Corporation and Subsidiaries	$ 0.1		$ (0.47)	$ (0.3)		$ (0.92)
Income (loss) per share - diluted: Attributable to VOXX International Corporation and Subsidiaries	$ 0.1		$ (0.47)	$ (0.3)		$ (0.92)
Weighted-average common shares outstanding (basic)	23,125,665		23,462,575	23,132,771		23,629,147
Weighted-average common shares outstanding (diluted)	23,159,333		23,462,575	23,132,771		23,629,147

[1] On March 1, 2024, the Company's majority owned subsidiary, EyeLock LLC, contributed assets, including inventory and intangible assets, to a newly formed joint venture, BioCenturion LLC, which will operate a Biometrics business. For the three and six months ended August 31, 2024 , the Company accounted for its investment in BioCenturion LLC as an equity method investment (see Note 12). Included in Income before taxes within the Consumer Electronics segment for the three and six months ended August 31, 2024 is a gain on the sale of a business in the amount of $ 8,300 and a gain on the sale of assets in the amount of $ 2,154 (see Note 2).

Consolidated Statements of Stoc

Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($) $ in Thousands		Total	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Accumulated Other Comprehensive Loss [Member]	Non-controlling Interests [Member]	Treasury Stock [Member]
Stockholders equity, beginning of period at Feb. 28, 2023		$ 305,716	$ 262	$ 292,565	$ 99,122	$ (18,680)	$ (37,268)	$ (30,285)
Net income (loss)	[1]	(11,387)			(10,738)		(649)
Other comprehensive Income (loss), net of tax		177				177
Repurchase of shares of Class A Common Stock		(4,113)						(4,113)
Stock-based compensation expense		235		235
Stockholders equity, end of period at May. 31, 2023		290,628	262	292,800	88,384	(18,503)	(37,917)	(34,398)
Stockholders equity, beginning of period at Feb. 28, 2023		305,716	262	292,565	99,122	(18,680)	(37,268)	(30,285)
Other comprehensive Income (loss), net of tax		1,026
Stockholders equity, end of period at Aug. 31, 2023		277,186	262	292,985	77,320	(17,654)	(38,470)	(37,257)
Stockholders equity, beginning of period at May. 31, 2023		290,628	262	292,800	88,384	(18,503)	(37,917)	(34,398)
Net income (loss)	[1]	(11,617)			(11,064)		(553)
Other comprehensive Income (loss), net of tax		849				849
Repurchase of shares of Class A Common Stock		(2,859)						(2,859)
Stock-based compensation expense		185		185
Stockholders equity, end of period at Aug. 31, 2023		277,186	262	292,985	77,320	(17,654)	(38,470)	(37,257)
Stockholders equity, beginning of period at Feb. 29, 2024		255,393	262	293,272	58,272	(17,366)	(39,474)	(39,573)
Net income (loss)	[1]	(9,892)			(9,269)		(623)
Other comprehensive Income (loss), net of tax		582				582
Cancellation of EyeLock LLC ownership put option, net of shareholder receivable (Note 22)		7,539		3,710			3,829
Cash settlement of market stock units upon vesting of remaining award		(1,000)		(1,000)
Repurchase of shares of Class A Common Stock		(248)						(248)
Stock-based compensation expense		62		62
Stockholders equity, end of period at May. 31, 2024		252,436	262	296,044	49,003	(16,784)	(36,268)	(39,821)
Stockholders equity, beginning of period at Feb. 29, 2024		255,393	262	293,272	58,272	(17,366)	(39,474)	(39,573)
Other comprehensive Income (loss), net of tax		147				147
Repurchase of shares of Class A Common Stock		(248)
Stockholders equity, end of period at Aug. 31, 2024		254,028	262	295,959	51,415	(17,219)	(36,568)	(39,821)
Stockholders equity, beginning of period at May. 31, 2024		252,436	262	296,044	49,003	(16,784)	(36,268)	(39,821)
Net income (loss)	[1]	2,112			2,412		(300)
Loss on contribution of assets to joint venture (Note 13)		(413)		(413)
Other comprehensive Income (loss), net of tax		(435)				(435)
Interest on shareholder note receivable		(45)		(45)
Stock-based compensation expense		373		373
Stockholders equity, end of period at Aug. 31, 2024		$ 254,028	$ 262	$ 295,959	$ 51,415	$ (17,219)	$ (36,568)	$ (39,821)

[1] Net (loss) income excludes net loss attributable to redeemable non-controlling interest of $( 286 ) for the three months ended May 31, 2024, $( 320 ) for the three months ended August 31, 2024, $( 317 ) for the three months ended May 31, 2023, and $( 961 ) for the three months ended August 31, 2023 (see Note 3).

Consolidated Statements of St_2

Consolidated Statements of Stockholders' Equity (Parenthetical) (Unaudited) - USD ($) $ in Thousands	3 Months Ended				6 Months Ended
	Aug. 31, 2024	May 31, 2024	Aug. 31, 2023	May 31, 2023	Aug. 31, 2024
Net loss attributable to redeembable non-controlling interest	$ (320)	$ (286)	$ (961)	$ (317)
Common Stock [Member]
Repurchase of shares of common stock		64,142	267,831	371,087
Common Class A [Member]
Repurchase of shares of common stock					64,142

Consolidated Statements of Cash

Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	6 Months Ended
	Aug. 31, 2024		Aug. 31, 2023
Cash flows from operating activities:
Net loss	$ (8,385)		$ (24,282)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization	5,729		6,492
Amortization of debt discount	206		196
Bad debt expense	52		38
Reduction in the carrying amount of the right of use asset	631		703
Gain on sale of business (Note 2)	(8,300)		0
Gain on sale of assets (Note 2)	(2,154)		0
Equity in income of equity investees	(551)	[1]	(2,857)
Distribution of income from equity investees	2,074		3,212
Deferred income tax expense (benefit)	1,329		(286)
Non-cash compensation adjustment	(430)		(119)
Stock based compensation expense	558		466
Loss (gain) on disposal of property, plant, and equipment	117		(31)
Gain on sale of intangible asset	0		(450)
Changes in operating assets and liabilities:
Accounts receivable	7,220		20,787
Inventory	4,223		1,490
Receivables from vendors	398		(230)
Prepaid expenses and other	4,796		(1,856)
Investment securities-trading	430		119
Accounts payable, accrued expenses, accrued sales incentives, contract liabilities, and other liabilities	6,636		(32)
Income taxes payable	(2,590)		(799)
Net cash provided by operating activities	11,989		2,561
Cash flows from investing activities:
Purchases of property, plant, and equipment	(1,736)		(1,444)
Proceeds from sale of property, plant, and equipment	3,202		33
Proceeds from sale of intangible asset	0		450
Net cash provided by (used in) investing activities	1,466		(961)
Cash flows from financing activities:
Principal payments on finance lease obligation	(204)		(169)
Proceeds from shareholder note receivable	352		0
Repayment of bank obligations	(83,273)		(76,630)
Borrowings on bank obligations	65,012		80,461
Deferred financing costs	0		(112)
Settlement of market stock unit awards	(1,000)		0
Purchase of treasury stock	(246)		(6,972)
Net cash used in financing activities	(19,359)		(3,422)
Effect of exchange rate changes on cash	(1,421)		1,622
Net decrease in cash and cash equivalents	(7,325)		(200)
Cash and cash equivalents at beginning of period	10,986		6,134
Cash and cash equivalents at end of period	$ 3,661		$ 5,934

[1] On March 1, 2024, the Company's majority owned subsidiary, EyeLock LLC, contributed assets, including inventory and intangible assets, to a newly formed joint venture, BioCenturion LLC, which will operate a Biometrics business. For the three and six months ended August 31, 2024 , the Company accounted for its investment in BioCenturion LLC as an equity method investment (see Note 12).

Pay vs Performance Disclosure

Pay vs Performance Disclosure - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
Pay vs Performance Disclosure - USD ($) $ in Thousands	Aug. 31, 2024	Aug. 31, 2023	Aug. 31, 2024	Aug. 31, 2023
Pay vs Performance Disclosure
Net Income (Loss)	$ 2,412	$ (11,064)	$ (6,857)	$ (21,802)

Insider Trading Arrangements

Insider Trading Arrangements	6 Months Ended
Insider Trading Arrangements	Aug. 31, 2024
Trading Arrangements, by Individual
Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false

Basis of Presentation

Basis of Presentation	6 Months Ended
Basis of Presentation	Aug. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of Presentation	(1) Basis of Presentation The accompanying unaudited interim consolidated financial statements of VOXX International Corporation and Subsidiaries ("Voxx" or the "Company") have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission as defined in the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 270 for interim financial information, and in accordance with accounting principles generally accepted in the United States of America (“GAAP”), and include all adjustments (consisting of normal recurring adjustments), which, in the opinion of management, are necessary to present fairly the consolidated financial position, results of operations, changes in stockholders’ equity, and cash flows for all periods presented. The results of operations are not necessarily indicative of the results to be expected for the full fiscal year or any interim period due to seasonal variations in operating results and other factors. These unaudited consolidated financial statements do not include all disclosures associated with audited consolidated financial statements prepared in accordance with GAAP. Accordingly, these statements should be read in conjunction with the Company's audited consolidated financial statements and notes thereto contained in the Company's Form 10-K for the fiscal year ended February 29, 2024. Certain amounts in the prior year have been reclassified to conform to the current year presentation. Due to an error recorded in the first quarter ended May 31, 2023, and a correction to the error recorded in the second quarter ended August 31, 2023, the quarter-to-date net loss attributable to the non-controlling interest for the periods ended May 31, 2023, and August 31, 2023, were understated and overstated, respectively, by $ 239 . The net loss attributable to non-controlling interest for the year-to-date periods presented for the six months ended August 31, 2023, and subsequent periods, were presented properly. The quarter-to-date net loss attributable to Voxx International Corporation and Subsidiaries for the three months ended May 31, 2023, and the three months ended August 31, 2023, were overstated, and understated, respectively, by $ 239 . We operate in three reportable segments: Automotive Electronics, Consumer Electronics, and Biometrics. See Note 23 for the Company's segment reporting disclosures.

Dispositions

Dispositions	6 Months Ended
Dispositions	Aug. 31, 2024
Acquisitions And Dispositions [Abstract]
Dispositions	(2) Dispositions Sale of a business On August 30, 2024, the Company's wholly owned subsidiary, VOXX Accessories Corp. ("VAC"), completed the sale of certain assets of its domestic accessories business ("the Disposal Group"), consisting of intangible assets and inventory, which was included in the Company's Consumer Electronics segment, to Talisman Brands Inc., d/b/a Established Inc. (“Established" or the "Buyer”) for total considera tion of $ 24,542 , net of selling expenses. The consideration was recorded as a receivable due from Established on the accompanying Consolidated Balance Sheet at August 31, 2024. The Company recognized a gain in the amount of $ 8,300 on the sale of the Disposal Group for the three and six months ended August 31, 2024 within Other income (expense) on the accompanying Unaudited Consolidated Statements of Operations and Comprehensive Income (Loss) . During September 2024, the Company received payments totaling $ 24,442 toward the total balance due from Established. The remaining balance due of $ 100 is expected to be received during the third quarter of Fiscal 2025. The proceeds of the sale will be used by the Company to repay outstanding debt. The sale of the Disposal Group has been recorded as a sale of a business pursuant to ASC 805 - Business Combinations, but did not meet the requirements to be classified as discontinued operations in accordance with ASC 205 - Presentation of Financial Statements, as the sale did not materially affect the Company's operations and did not represent a strategic shift for the Company. At closing, the Company and Established entered into an operations services agreement, pursuant to which the Company agreed to continue to operate the accessories business for the Buyer's benefit, consisting of certain defined services, including purchasing, logistics, sales, MIS, human resources, customer service, credit and collections, and finance and accounting services. The operating services agreement will continue for a period of twelve months, and may be canceled at any time, or extended, at the Buyer's option. Sale of assets On August 15, 2024, the Company's wholly owned subsidiary, Premium Audio Company, LLC ("PAC"), completed the sale of certain trade names and related inventory to Jamo Holding Limited and Cinemaster Shanghai Ltd. for total considera tion of $ 3,410 . The assets sold did not meet the requirements to be classified as a sale of a business pu rsuant to ASC 805 - Business Combination s. The Company recognized a gain of $ 2,154 on the sale of these assets for the three and six months ended August 31, 2024 within Other income (expense) on the accompanying Unaudited Consolidated Statements of Operations and Comprehensive Income (Loss) . The proceeds of the sale were used by the Company to repay outstanding debt.

Redeemable Non-Controlling Inte

Redeemable Non-Controlling Interest	6 Months Ended
Redeemable Non-Controlling Interest	Aug. 31, 2024
Redeemable Non-Controlling Interest [Abstract]
Redeemable Non-Controlling Interest	(3) Redeemable Non-Controlling Interest On September 8, 2021, Onkyo Technology KK ("Onkyo"), a joint venture between the Company's subsidiary, Premium Audio Company LLC ("PAC"), and its partner Sharp Corporation ("Sharp"), completed a transaction to acquire certain assets of the home audio/video business of Onkyo Home Entertainment Corporation (“OHEC”). PAC owns 77.2 % of the joint venture and has an 85.1 % voting interest and Sharp owns 22.8 % of the joint venture and has a 14.9 % voting interest. The joint venture agreement between PAC and Sharp contains a put/call option, whereby Sharp has the right to put its interest in the joint venture back to Voxx and Voxx has the right to call Sharp’s ownership interest in the joint venture at any time after the approval of Onkyo’s annual financial statements for the year ending February 28, 2025 at a purchase price equal to the higher of (a) the assets of Onkyo minus the liabilities of Onkyo, or (b) five times the EBITDA of Onkyo, in either case (a) or (b), less any amounts distributed to Sharp at any time (provided all shareholder loans are repaid) multiplied by the percentage of votes attached to such shares and other interests, free from all encumbrances, and with the benefit of all rights attaching to them as at the date of the relevant notice. The Company has consolidated the financial results of Onkyo since the acquisition date for financial reporting purposes. The non-controlling interest has been classified as redeemable non-controlling interest outside of equity on the accompanying Consolidated Balance Sheets as the exercise of the put/call option is not within the Company’s control. The carrying value of the redeemable non-controlling interest of Onkyo cannot be less than the redemption amount, which is the amount Sharp will settle the put option for if exercised. Based upon the terms of the put/call option, the option remains exercisable in the event there is no redemption price, or if the redemption price is a negative amount, as determined by the redemption formula. In periods where the specific formula results in a negative amount, and thus no redemption value exists, no amounts would be paid to or received from the counterparty upon the exercise of the option. Adjustments to reconcile the carrying value to the redemption amount are recorded immediately to retained earnings and included in earnings per share. No adjustment was made to the carrying amount of the redeemable non-controlling interest at August 31, 2024 as the excess of the redemption amount over the carrying amount was minimal, or a negative amount. In the event the formulaic redemption price is positive and greater than the carrying amount of the redeemable non-controlling interest balance, an adjustment to the carrying amount of the non-controlling interest would be recorded. The following table provides the rollforward of the redeemable non-controlling interest for the six months ended August 31, 2024: Redeemable Non-controlling Interest Balance at February 29, 2024 $ ( 3,203 ) Net loss attributable to non-controlling interest ( 606 ) Comprehensive loss attributable to non-controlling interest ( 104 ) Foreign currency translation ( 128 ) Balance at August 31, 2024 $ ( 4,041 )

Net Income (Loss) Per Common Sh

Net Income (Loss) Per Common Share	6 Months Ended
Net Income (Loss) Per Common Share	Aug. 31, 2024
Net Income Per Common Share [Abstract]
Net Income (Loss) Per Common Share	(4) Net Income (Loss) Per Common Share Basic net income (loss) per common share attributable to VOXX International Corporation is calculated by dividing net income (loss) attributable to Voxx, adjusted to reflect changes in the redemption value of redeemable non-controlling interest, by the weighted-average common shares outstanding during the period. The diluted net income (loss) per common share computation reflects the potential dilution that would occur if common stock equivalent securities or other contracts to issue common stock were exercised or converted into common stock. A reconciliation between the denominator of basic and diluted net income (loss) per common share is as follows: Three months ended Six months ended 2024 2023 2024 2023 Weighted-average common shares outstanding (basic) 23,125,665 23,462,575 23,132,771 23,629,147 Effect of dilutive securities: Restricted stock units, market stock units, and stock grants 33,668 — - - Weighted-average common shares and potential common shares outstanding (diluted) 23,159,333 23,462,575 23,132,771 23,629,147 Restricted stock units, market stock units, and stock grants of 106,862 and 290,173 for the three months ended August 31, 2024 and 2023, respectively, and 264,085 and 292,877 for the six months ended August 31, 2024 and 2023, respectively, were not included in the net income (loss) per diluted share calculation because the grant prices of the restricted stock units, market stock units, and stock grants were greater than the average market price of the Company’s common stock during these periods, or the inclusion of these components would have been anti-dilutive.

Investment Securities

Investment Securities	6 Months Ended
Investment Securities	Aug. 31, 2024
Investment Securities [Abstract]
Investment Securities	(5) Investment Securities As of August 31, 2024, and February 29, 2024, the Company had the following investments: August 31, 2024 Fair Value Investment Securities Marketable Equity Securities Mutual funds $ 398 Total Marketable Equity Securities 398 Total Investment Securities $ 398 February 29, 2024 Fair Value Investment Securities Marketable Equity Securities Mutual funds $ 828 Total Marketable Securities 828 Total Investment Securities $ 828 Equity Securities Mutual Funds The Company’s mutual funds are held in connection with its deferred compensation plan, which was terminated on May 1, 2023, with payment of the remaining balance to be made to participating employees on March 1, 2025. Changes in the carrying value of these securities are offset by changes in the corresponding deferred compensation liability.

Fair Value Measurements and Der

Fair Value Measurements and Derivatives	6 Months Ended
Fair Value Measurements and Derivatives	Aug. 31, 2024
Fair Value Disclosures [Abstract]
Fair Value Measurements and Derivatives	(6) Fair Value Measurements and Derivatives The Company applies the authoritative guidance on “Fair Value Measurements," which, among other things, requires enhanced disclosures about assets and liabilities that are measured and reported at fair value. This guidance establishes a hierarchal disclosure framework that prioritizes and ranks the level of market price observability used in measuring these assets and liabilities at fair value. Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Fair value is best determined based upon quoted market prices. However, in many instances, there are no quoted market prices for the Company’s various assets and liabilities. In cases where quoted market prices are not available, fair values are based on estimates using present value or other valuation techniques. Those techniques are significantly affected by the assumptions used, including the discount rate and estimates of future cash flows. Accordingly, the fair value estimates may not be realized in an immediate settlement of the assets and liabilities. Assets and liabilities measured and reported at fair value are classified and disclosed in one of the following categories: Level 1 - Quoted market prices in active markets for identical assets or liabilities. Level 2 - Inputs other than Level 1 inputs that are either directly or indirectly observable. Level 3 - Unobservable inputs developed using the Company's estimates and assumptions, which reflect those that market participants would use. The following table presents financial assets and liabilities measured at fair value on a recurring basis at August 31, 2024: Fair Value Measurements at Total Level 1 Level 2 Level 3 Assets: Cash and money market funds $ 3,661 $ 3,661 $ - $ - Mutual funds 398 398 - - Derivatives designated for hedging 143 - 143 - The following table presents financial assets and liabilities measured at fair value on a recurring basis at February 29, 2024: Fair Value Measurements at Total Level 1 Level 2 Level 3 Assets: Cash and money market funds $ 10,986 $ 10,986 $ - $ - Mutual funds 828 $ 828 $ - $ - Derivatives designated for hedging 263 - 263 - The carrying value of our other financial instruments did not differ materially from their estimated fair values at August 31, 2024 and February 29, 2024. Derivative Instruments The Company’s derivative instruments include an interest rate swap agreement and foreign currency contracts. The Company’s interest rate swap agreement hedges interest rate exposure related to the outstanding balance of its Florida Industrial Revenue Bonds ("the Florida Mortgage"), with monthly payments due through March 2026. The swap agreement locks the interest rate on the debt at 3.43 % (inclusive of credit spread) through the maturity date of the loan. Interest rate swap agreements qualifying for hedge accounting are designated as cash flow hedges and valued based on a comparison of the change in fair value of the actual swap contracts designated as the hedging instruments and the change in fair value of a hypothetical swap contract (Level 2). We calculate the fair value of our interest rate swap agreement quarterly based on the quoted market price for the same or similar financial instruments. Interest rate swaps are classified in the balance sheet as either assets or liabilities based on the fair value of the instruments at the end of the period. The current outstanding notional value of the Company's interest rate swap at August 31, 2024 is $ 5,365 (see Note 27). Foreign currency contracts are utilized by our German subsidiary to hedge a portion of their U.S. Dollar company’s inventory purchases when management views them to be advantageous. The valuation of our foreign currency options is performed based on foreign exchange rates and yield curves built from observable market parameters and, where applicable, on Black Scholes or local volatility models calibrated to available volatility quotes (Level 2). During Fiscal 2024 and during the three months ended August 31, 2024 , the Company entered into forward foreign currency contracts which have notional U.S. Dollar equivalent amounts aggregating $ 20,700 at August 31, 2024, and that have been designated as cash flow hedges. The remaining maturities of these option contracts are eighteen months in the aggregate. During the six months ended August 31, 2023, the Company had no open forward foreign currency contracts. Financial Statement Classification The following table discloses the fair value as of August 31, 2024 and February 29, 2024 of the Company’s derivative instruments: Derivative Assets and Liabilities Fair Value Account August 31, 2024 February 29, 2024 Derivative instruments Foreign currency contracts designated as cash flow hedges Prepaid expenses and other current assets $ 68 $ 121 Interest rate swap agreements designated as cash flow hedges Other assets 75 142 Total derivatives $ 143 $ 263 Cash Flow Hedges The change in the fair value of hedging derivative instruments that are expected to be highly effective and have been designated and qualify as cash flow hedges are recorded to Other comprehensive loss (income). During the same period or periods during which the hedged transaction affects earnings, the amounts recorded in Other comprehensive loss (income) are reclassified to earnings and presented in the same income statement line item as the effect of the hedged item. The change in fair value of the derivative instruments that do not qualify for hedge accounting and have not been designated as cash flow hedges are included in other (expense) income on the accompanying Unaudited Consolidated Statements of Operations and Comprehensive Income (Loss) immediately. The gain or loss on the Company’s interest rate swap is recorded in Other comprehensive loss (income) and subsequently reclassified into Interest and bank charges in the period in which the hedged transaction affects earnings. As of August 31, 2024 , no interest rate swaps originally designated for hedge accounting were de-designated or terminated. The net income (loss) recognized in Other comprehensive (loss) income for foreign currency contracts is expected to be recognized in Cost of sales during the next twenty-four months. No amounts were excluded from the assessment of hedge effectiveness during the respective periods. Activity related to cash flow hedges recorded during the three and six months ended August 31, 2024 and 2023 was as follows: Three months ended Six months ended August 31, 2024 August 31, 2024 Pretax Gain (Loss) Pretax Loss Pretax Gain (Loss) Pretax Loss Cash flow hedges Foreign currency contracts 1 ( 37 ) 13 ( 68 ) Interest rate swaps $ ( 67 ) $ - ( 67 ) - Three months ended Six months ended August 31, 2023 August 31, 2023 Pretax Gain Pretax Gain (Loss) Pretax Loss Pretax Gain (Loss) Cash flow hedges Foreign currency contracts - - $ - $ - Interest rate swaps 34 - ( 26 ) -

Accumulated Other Comprehensive

Accumulated Other Comprehensive (Loss) Income	6 Months Ended
Accumulated Other Comprehensive (Loss) Income	Aug. 31, 2024
Other Comprehensive Income [Abstract]
Accumulated Other Comprehensive (Loss) Income	(7) Accumulated Other Comprehensive (Loss) Income The Company’s accumulated other comprehensive (loss) income consists of the following: Foreign Pension plan Derivatives Total Balance at February 29, 2024 $ ( 17,192 ) $ ( 398 ) $ 224 $ ( 17,366 ) Other comprehensive income (loss) before reclassifications 258 ( 8 ) ( 57 ) 193 Reclassified from accumulated other comprehensive loss (gain) - - ( 46 ) ( 46 ) Net current-period other comprehensive loss 258 ( 8 ) ( 103 ) 147 Balance at August 31, 2024 $ ( 16,934 ) $ ( 406 ) $ 121 $ ( 17,219 ) For the three and six months ended August 31, 2024, the Company recorded other comprehensive (loss) income, net of associated tax impact of $( 12 ) and $( 18 ) , respectively, related to derivatives designated in a hedging relationship. There were no taxes recorded related to pension plan adjustments during the three and six months ended August 31, 2024. The other comprehensive (loss) income before reclassification related to foreign currency translation losses of $ 258 includes the remeasurement of intercompany transactions of a long-term investment nature of $( 602 ) with certain subsidiaries whose functional currency is not the U.S. dollar, and $ 860 from translating the financial statements of the Company's non-U.S. dollar functional currency subsidiaries into our reporting currency, which is the U.S. dollar.

Supplemental Cash Flow Informat

Supplemental Cash Flow Information	6 Months Ended
Supplemental Cash Flow Information	Aug. 31, 2024
Supplemental Cash Flow Information [Abstract]
Supplemental Cash Flow Information	(8) Supplemental Cash Flow Information The following is supplemental information relating to the Unaudited Consolidated Statements of Cash Flows: Six months ended 2024 2023 Non-cash investing and financing activities: Recording of redeemable equity $ ( 63 ) $ ( 46 ) Investment in BioCenturion LLC 2,989 - Cancellation of EyeLock LLC ownership put option 9,817 - Reclassification of shareholder receivable to equity 2,578 - Recording of excise tax attributable to treasury stock repurchases 2 - Right of use assets obtained in exchange for operating lease obligations 556 549 Right of use assets obtained in exchange for finance lease obligations - 575 Cash paid for amounts included in the measurement of lease liabilities: Operating cash flows from operating leases $ 610 $ 648 Operating cash flows from finance leases 30 8 Finance cash flows from finance leases 204 169 Cash paid during the period: Interest (excluding bank charges) $ 3,211 $ 2,135 Income taxes (net of refunds) 2,270 910

Accounting for Stock-Based Comp

Accounting for Stock-Based Compensation	6 Months Ended
Accounting for Stock-Based Compensation	Aug. 31, 2024
Accounting For Stock Based Compensation [Abstract]
Accounting for Stock-Based Compensation	(9) Accounting for Stock-Based Compensation The Company has various stock-based compensation plans, which are more fully described in Note 1 of the Notes to the Consolidated Financial Statements contained in the Company’s Form 10-K for the fiscal year ended February 29, 2024. The Company's 2024 Equity Incentive Plan (the "2024 Plan") was adopted by the Company's Board of Directors and approved by the Company's shareholders at its Annual Meeting of Shareholders in July 2024 and replaces the Company's 2012 Equity Incentive Plan (the "2012 Plan") and 2014 Omnibus Equity Incentive Plan (the "2014 Plan"). Restricted stock awards are granted pursuant to the 2024 Plan. A restricted stock award is an award of common stock that is subject to certain restrictions during a specified period. Restricted stock awards are independent of option grants and are subject to forfeiture if employment terminates for a reason other than death, disability, or retirement prior to the release of the restrictions. Pursuant to the 2024 Plan, Restricted Stock Units ("RSUs") may be awarded by the Company to any individual who is employed by, provides services to, or serves as a director of the Company or its affiliates. There are no market conditions inherent in the RSU awards, only the employee performance requirement for performance awards, and the service requirement that the respective employee continues employment with the Company through the vesting date. In August 2024, the Company granted 267,924 RSUs to certain employees of the Company pursuant to the 2024 Plan. The RSU awards will vest on the the occurrence of certain triggering conditions as described in the awards. The restricted stock units will also vest upon the sale of all of the Company's issued and outstanding stock, the sale of all, or substantially all, of the assets of the Company, or the termination of the grantee's employment without cause. When vested, the RSU awards will be settled, at the Company's discretion, in cash or in shares of the Company's Class A Common Stock, or a combination of both. The Company expenses the cost of these RSU awards on a straight-line basis over the requisite service period of each grantee, which is determined to be eighteen months based on the award triggering conditions. For these purposes, the fair market value of each RSU was determined based on the closing price of the Company's common stock on the grant date. The fair market value of each RSU granted in August 2024 was $ 3.12 . The Company also grants RSUs to certain senior executives of the Company under its Senior Executive Retirement Plan ("SERP") pursuant to the 2024 Plan. These RSUs vest on the later of three years from the date of grant, or the grantee reaching the age of 65 years. The RSU awards will also vest upon the sale of all of the Company's issued and outstanding stock, the sale of all, or substantially all, of the assets of a subsidiary of which the grantee serves as CEO and/or President, or the termination of the grantee's employment without cause, provided that the grantee, at the time of termination, has been employed for at least 10 years. When vested, RSU awards may be settled in shares of Class A Common Stock or in cash, at the Company's sole option. In July 2024, the Company granted 49,983 RSU awards to employees under the SERP. The Company expenses the cost of these RSU awards on a straight-line basis over the requisite service period of each grantee. For these purposes, the fair market value of each RSU is determined based on the mean of the high and low price of the Company's common stock on the grant date. The fair market value of each RSU granted in July 2024 w as $ 2.56 . Grant of Shares to President and Chief Executive Officer On July 8, 2019, the Board of Directors approved a five-year Employment Agreement (the “Employment Agreement”), effective March 1, 2019, by and between the Company and Patrick M. Lavelle, the Company’s President and Chief Executive Officer. Under the terms of the Employment Agreement, in addition to a $ 1,000 annual salary and a cash bonus based on the Company’s Adjusted EBITDA, Mr. Lavelle was granted the right to receive certain stock-based compensation as discussed below: - An initial stock grant of 200,000 fully vested shares of Class A Common Stock issued in July 2019 under the 2012 Plan. - Additional stock grants of 100,000 shares of Class A Common Stock issued on each of March 1, 2020, March 1, 2021, and March 1, 2022 under the 2012 Plan. - Grant of market stock units (“MSU’s”) up to a maximum value of $ 5,000 , based upon the achievement of a 90-calendar day average stock price of no less than $ 5.49 over the performance period ending on the third and fifth anniversary of the effective date of the Employment Agreement. The value of the MSU award increased based upon predetermined targeted 90-calendar day average stock prices with a maximum of $ 5,000 if the 90-calendar day average high stock price equaled or exceeded $ 15.00 . The award could be settled in shares or in cash upon mutual agreement between the Company and Mr. Lavelle. We recognized stock-based compensation expense of $ 23 and $ 46 during the three and six months ended August 31, 2023 related to these MSU’s using the graded vesting attribution method over the performance period. For the three and six months ended August 31, 2024 , no remaining compensation expense was recognized related to the MSU's, as the remaining 20 % of this award vested on March 1, 2024 and was settled in cash, resulting in a payment made to Mr. Lavelle in the amount of $ 1,000 during the first quarter of Fiscal 2025. On September 28, 2023, the term of Mr. Lavelle's employment agreement was extended for one year through February 28, 2025 under which his annual salary will be $ 750 and he will receive a $ 250 cash equivalent share grant to be awarded in quarterly increments calculated on the fair market value of the Company's Class A Common Stock on each of June 30, 2024, September 30, 2024, December 31, 2024, and March 31, 2025. We recognized stock-based compensation expense of $ 46 and $ 105 during the three and six months ended August 31, 2024, respectively, related to this stock grant, which has been recorded using the graded vesting attribution method. All stock grants under the Employment Agreement are subject to a hold requirement as specified in the Employment Agreement. The Employment Agreement gives Mr. Lavelle the right to require the Company to redeem his shares if a specific contingent change in control event occurs. The contingent event under which Mr. Lavelle may exercise his right to redemption includes a change of control transaction wherein the Shalam Group would become a 40% or less holder of the total combined voting power of all outstanding voting securities of the Company. Accordingly, the stock awards issued in connection with the Employment Agreement are presented as redeemable equity on the Consolidated Balance Sheets at grant-date fair value. Shares previously held by Mr. Lavelle under the 2014 Plan and those personally purchased by Mr. Lavelle are also presented as redeemable equity. As the contingent events that would allow Mr. Lavelle to redeem the shares are not probable at this time, remeasurement of the amounts in redeemable equity have not been recorded. The Employment Agreement contains certain restrictive and non-solicitation covenants. A rollforward of redeemable equity related to stock awards and shares held by Mr. Lavelle for the six months ended August 31, 2024 is as follows: Redeemable Equity Balance at February 29, 2024 $ 4,110 Stock based compensation expense 63 Balance at August 31, 2024 $ 4,173 Grant of Shares to Chief Financial Officer and Chief Operating Officer On July 8, 2019, the Board of Directors approved a five-year Employment Agreement, effective March 1, 2019, by and between the Company and Loriann Shelton, the Company’s Chief Financial Officer and Chief Operating Officer. On September 28, 2023, the term of the agreement was extended for one year through February 28, 2025 under which Ms. Shelton will receive, in addition to her annual salary, a $ 100 cash equivalent share grant to be awarded in quarterly increments calculated on the fair market value of the Company's Class A Common Stock on each of June 30, 2024, September 30, 2024, December 31, 2024, and March 31, 2025. We recognized stock-based compensation expense of $ 18 and $ 42 during the three and six months ended August 31, 2024, respectively, related to this stock grant, which has been recorded using the graded vesting attribution method. Grant of Shares to Beat Kahli On February 6, 2023, Voxx appointed Beat Kahli, the Vice Chairman of the Company's Board of Directors, President of the Company for one year. The Company entered into an employment agreement with Mr. Kahli effective February 6, 2023 with a term ending on February 29, 2024. Under the terms of the employment agreement, in addition to a $ 300 annual salary, Mr. Kahli was granted the right to receive stock-based compensation in the form of a stock grant of 20,000 shares of the Company's Class A Common Stock to be issued on each of June 30, 2023, September 30, 2023, December 31, 2023 and March 31, 2024. We recognized stock-based compensation expense of $ 4 during the six months ended August 31, 2024 , compared to $ 57 and $ 154 during the three and six months ended August 31, 2023 , respectively, related to this stock grant. There was no remaining compensation expense related to this grant during the three months ended August 31, 2024. The grant fair value of these shares was $ 10.66 per share and compensation expense has been recorded using the graded vesting attribution method. Mr. Kahli's employment agreement expired on February 29, 2024. He remains Vice Chairman of the Company's Board of Directors. On March 1, 2024, Patrick Lavelle resumed the role of President of the Company. The following table presents a summary of the activity related to the 2024 Plan for the six months ended August 31, 2024: Number Weighted Unvested award balance at February 29, 2024 176,312 $ 8.93 Granted 317,907 3.03 Vested ( 100,792 ) 6.17 Vested and settled ( 5,000 ) 10.66 Unvested award balance at August 31, 2024 388,427 $ 4.02 At August 31, 2024, there were 706,087 vested and unsettled RSU awards under the Company’s 2024 Plan with a weighted average fair value of $ 6.93 . During the three and six months ended August 31, 2024 and 2023, the Company recorded $ 412 and $ 558 , respectively, and $ 208 and $ 466 , respectively, in total stock-based compensation related to the 2024 Plan, including executive employment agreements. As of August 31, 2024, there was approximately $ 1,270 of unrecognized stock-based compensation expense related to unvested RSU awards and stock grants.

Supply Chain Financing

Supply Chain Financing	6 Months Ended
Supply Chain Financing	Aug. 31, 2024
Supply Chain Financing [Abstract]
Supply Chain Financing	(10) Supply Chain Financing The Company has supply chain financing agreements and factoring agreements that were entered into for the purpose of accelerating receivable collection and better managing cash flow. The balances under the agreements are sold without recourse and are accounted for as sales of accounts receivable. Total receivable balances sold for the three and six months ended August 31, 2024, net of discounts, were $ 22,024 and $ 41,207 , respectively, compared to $ 28,278 and $ 55,633 for the three and six months ended August 31, 2023 , respectively.

Research and Development

Research and Development	6 Months Ended
Research and Development	Aug. 31, 2024
Research and Development [Abstract]
Research and Development	(11) Research and Development Expenditures for research and development are charged to expense as incurred. Such expenditures amounted to $ 1,235 and $ 2,606 for the three and six months ended August 31, 2024, respectively, compared to $ 2,079 and $ 4,455 for the three and six months ended August 31, 2023, respectively. All amounts are net of customer reimbursements and are included within Engineering and technical support expenses on the Unaudited Consolidated Statements of Operations and Comprehensive Income (Loss) .

Goodwill and Intangible Assets

Goodwill and Intangible Assets	6 Months Ended
Goodwill and Intangible Assets	Aug. 31, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill and Intangible Assets	(12) Goodwill and Intangible Assets The change in goodwill by segment is as follows: Automotive Electronics: Amount Beginning balance at March 1, 2024 $ 3,052 Activity during the period - Balance at August 31, 2024 $ 3,052 Gross carrying value at August 31, 2024 $ 10,425 Accumulated impairment charge ( 7,373 ) Net carrying value at August 31, 2024 $ 3,052 Consumer Electronics: Beginning balance at March 1, 2024 $ 60,879 Foreign currency adjustments 413 Balance at August 31, 2024 $ 61,292 Gross carrying value at August 31, 2024 $ 93,455 Accumulated impairment charge ( 32,163 ) Net carrying value at August 31, 2024 $ 61,292 Total Goodwill, net $ 64,344 The Company's Biometrics segment did no t carry a goodwill balance at August 31, 2024 or February 29, 2024 . At August 31, 2024, intangible assets consisted of the following: Gross Accumulated Total Net Finite-lived intangible assets: Customer relationships $ 54,053 $ 47,678 $ 6,375 Trademarks/Tradenames 20,588 6,219 14,369 Developed technology 4,965 2,979 1,986 Patents 6,735 6,222 513 License 1,400 1,400 - Contracts 1,556 1,556 - Total finite-lived intangible assets $ 89,297 $ 66,054 23,243 Indefinite-lived intangible assets Trademarks 33,389 Total intangible assets, net $ 56,632 At February 29, 2024, intangible assets consisted of the following: Gross Accumulated Total Net Finite-lived intangible assets: Customer relationships $ 53,915 $ 46,037 $ 7,878 Trademarks/Tradenames 20,323 5,031 15,292 Developed technology 18,970 15,743 3,227 Patents 6,736 6,128 608 License 1,400 1,400 - Contracts 1,556 1,556 - Total finite-lived intangible assets $ 102,900 $ 75,895 27,005 Indefinite-lived intangible assets Trademarks 41,761 Total intangible assets, net $ 68,766 The Company recorded amortization expense of $ 1,573 and $ 3,153 for the three and six months ended August 31, 2024, respectively, compared to $ 1,640 and $ 3,320 for the three and six months ended August 31, 2023 , respectively. The estimated aggregate amortization expense for all amortizable intangibles for August 31 of each of the succeeding years is as follows: Year Amount 2025 $ 5,694 2026 4,306 2027 3,110 2028 2,908 2029 2,866

Equity Investments

Equity Investments	6 Months Ended
Equity Investments	Aug. 31, 2024
Equity Method Investment, Summarized Financial Information [Abstract]
Equity Investment	(13) Equity Investments BioCenturion LLC On March 1, 2024, the Company's majority owned subsidiary, EyeLock LLC, entered into a joint venture agreement with GalvanEyes Partners LLC to form BioCenturion LLC ("BioCenturion," or the "joint venture") (see Note 22). EyeLock contributed assets with a net book value totaling $ 3,403 into the newly created BioCenturion LLC in exchange for a 50 % membership interest in the joint venture. The following summarizes the preliminary allocation of the assets contributed to the joint venture by EyeLock on March 1, 2024 based upon their fair values: March 1, 2024 Assets contributed: Inventory $ 1,839 Accounts receivable, net 46 Property, plant, and equipment 4 Tradenames 1,630 Developed technology 2,460 Total contribution $ 5,979 BioCenturion LLC operates in the biometrics business. All working capital needs and funding of the joint venture shall be borne by GalvanEyes for the first two years of the joint venture agreement and GalvanEyes will control the day-to-day operations of BioCenturion. Beat Kahli, who previously served as President of Voxx and as CEO of GalvanEyes, and currently serves as Vice-chairman of Voxx's Board of Directors, is Chairman of the Board and Chief Executive Officer of BioCenturion LLC. The Company has concluded that BioCenturion is a variable interest entity for which EyeLock lacks the power to direct the activities that most significantly impact the joint venture's economic performance. As EyeLock is not the primary beneficiary, it does not consolidate the variable interest entity. However, due to EyeLock's ability to exercise significant influence, the investment is accounted for under the equity method of accounting in accordance with ASC 323, "Investments - Equity Method and Joint Ventures." The investment in BioCenturion LLC was recorded at its initial fair value of $ 2,989 on March 1, 2024 in accordance with ASC 810-10-40 upon the deconsolidation of the group of assets, which represented a business pursuant to ASC 805, "Business Combinations." EyeLock incurred a loss on the contribution of assets to the joint venture of $ 413 for the six months ended August 31, 2024, which was recorded to Paid in capital on the Company's Consolidated Balance Sheet. The Company will apply the hypothetical liquidation book value method ("HLBV") to determine the allocation of profits and losses of the joint venture to EyeLock. The liquidation rights and priorities are defined in the joint venture operating agreement as 77.8 % to EyeLock and 22.2 % to GalvanEyes up to the deemed initial capital contributions of $ 45,000 , and thereafter 50 % to EyeLock and 50 % to GalvanEyes, which differs from the membership interest of EyeLock and GalvanEyes, which is 50 % to both EyeLock and GalvanEyes. The HLBV method calculates the proceeds that would be attributable to each member in an investment based on the liquidation provisions of the agreement if the joint venture was to be liquidated at book value as of the balance sheet date. Each member’s allocation of income or loss in the period is equal to the change in the amount of net equity they are legally able to claim based on a hypothetical liquidation of the entity at the end of a reporting period compared to the beginning of that period, adjusted for any capital transactions. EyeLock's share of losses from BioCenturion was $ 601 and $ 1,365 for the three and six months ended August 31, 2024. The balance of EyeLock's equity method investment in BioCenturion at August 31, 2024 was $ 1,625 . ASA Electronics LLC and Subsidiary As of August 31, 2024 and February 29, 2024 , the Company had a 50 % non-controlling ownership interest in ASA Electronics, LLC and Subsidiary (“ASA"), which acts as a distributor of mobile electronics specifically designed for niche markets within the automotive industry, including RV's; buses; and commercial, heavy duty, agricultural, construction, powersport, and marine vehicles. The following presents summary financial information for ASA. Such summary financial information has been provided herein based upon the individual significance of ASA to the consolidated financial information of the Company. August 31, 2024 February 29, 2024 Current assets $ 43,390 $ 43,790 Non-current assets 7,386 7,579 Liabilities 8,330 8,609 Members' equity 42,446 42,760 Six months ended 2024 2023 Net sales $ 32,286 $ 42,192 Gross profit 8,638 11,115 Operating income 3,294 5,321 Net income 3,832 5,714 The Company's share of income from ASA was $ 801 and $ 1,916 for the three and six months ended August 31, 2024, respectively, compared to $ 1,241 and $ 2,857 for the three and six months ended August 31, 2023, respectively. The balance of the Company's equity method investment in ASA at August 31, 2024 was $ 21,223 .

Income Taxes

Income Taxes	6 Months Ended
Income Taxes	Aug. 31, 2024
Income Tax Disclosure [Abstract]
Income Taxes	(14) Income Taxes The Company’s provision for income taxes consists of federal, foreign, and state taxes necessary to align the Company’s year-to-date tax provision with the annual effective rate that it expects to achieve for the full year. At each interim period, the Company updates its estimate of the annual effective tax rate and records cumulative adjustments, as necessary. At each interim period, the Company evaluates the realizability of its deferred tax assets to determine if a valuation allowance is required. Given the VAC sale of business that occurred in the interim quarter ended August 31, 2024, the Company determined that its Canadian deferred tax assets will not be realizable on a more-likely-than-not basis. As such, the Company recorded an increase to its valuation allowance as a discrete item during the quarter. For the three months ended August 31, 2024 , the Company recorded an income tax provision of $ 1,600 , which includes a discrete income tax provision of $ 1,265 primarily related to increases in its valuation allowance in connection with deferred tax assets in Canada and Australia. The effective tax rate for the three months ended August 31, 2024 was an income tax provision of 47.2 % on pre-tax income of $ 3,392 . The effective tax rate for the three months ended August 31, 2024 differed from the U.S. statutory rate of 21 % mostly related to the discrete items discussed above, as well as a number of factors including no income tax benefit recorded on current year U.S and Japanese pre-tax losses given the Company maintains a full valuation allowance, income taxed in foreign jurisdictions at varying tax rates, nondeductible permanent differences, research and development credits, and adjustments to the deferred tax liability related to indefinite lived intangibles. For the three months ended August 31, 2023, the Company recorded an income tax provision of $ 1,170 , which includes a discrete income tax provision of $ 115 . The effective tax rate for the three months ended August 31, 2023 was an income tax provision of 10.3 % on pre-tax loss of $ 11,407 . The effective tax rate for the three months ended August 31, 2023 differs from the U.S. statutory rate of 21 % as a result of a number of factors, primarily related to no income tax benefit recorded on current year U.S and Japanese pre-tax losses given the Company maintains a full valuation allowance, income taxed in foreign jurisdictions at varying tax rates, nondeductible permanent differences, research and development credits, and adjustments to our deferred tax liability related to indefinite lived intangibles. For the six months ended August 31, 2024, the Company recorded an income tax provision of $ 1,006 , which includes a discrete income tax provision of $ 1,158 related primarily to increases in valuation allowance related to deferred tax assets in Canada (as discussed above) and Australia. The effective tax rate for the six months ended August 31, 2024 was an income tax expense of 13.6 % on pre-tax loss of $ 7,379 . The effective tax rate for the six months ended August 31, 2024 differs from the U.S. statutory rate of 21 % as a result of a number of factors, primarily related to no income tax benefit recorded on current year U.S. and Japanese pre-tax losses given the Company maintains a full valuation allowance, income taxed in foreign jurisdictions at varying tax rates, nondeductible permanent differences, research and development credits, adjustments to the deferred tax liability related to indefinite lived intangibles, and the discrete items discussed above. For the six months ended August 31, 2023, the Company recorded an income tax benefit of $ 151 , which includes a discrete income tax benefit of $ 317 related primarily to the reversal of uncertain tax position liabilities as a result of the lapse of the applicable statute of limitations offset by the remeasurement of state deferred taxes based on law changes enacted during the period. The effective tax rate for the six months ended August 31, 2023 was an income tax benefit of 0.6 % on pre-tax loss of $ 24,433 . The effective tax rate for the six months ended August 31, 2023 differs from the U.S. statutory rate of 21 % as a result of a number of factors, primarily related to no income tax benefit recorded on current year U.S and Japanese pre-tax losses given the Company maintains a full valuation allowance, income taxed in foreign jurisdictions at varying tax rates, nondeductible permanent differences, research and development credits, and adjustments to our deferred tax liability related to indefinite lived intangibles. At August 31, 2024 and February 29, 2024 , the Company had an uncertain tax position liability balance of $ 721 and $ 809 , respectively, including interest and penalties. The unrecognized tax benefits include amounts related to various U.S. federal, state, and local, and foreign tax issues.

Inventory

Inventory	6 Months Ended
Inventory	Aug. 31, 2024
Inventory Disclosure [Abstract]
Inventory	(15) Inventory Inventories by major category are as follows: August 31, February 29, Raw materials $ 17,522 $ 21,527 Work in process 577 736 Finished goods 95,154 106,208 Inventory $ 113,253 $ 128,471

Product Warranties and Product

Product Warranties and Product Repair Costs	6 Months Ended
Product Warranties and Product Repair Costs	Aug. 31, 2024
Payables And Accruals Warranties [Abstract]
Product Warranties and Product Repair Costs	(16) Product Warranties and Product Repair Costs The following table provides a summary of the activity with respect to product warranties and product repair costs. The liability for product warranties is included within Accrued expenses and other current liabilities and the reserve for product repair costs is recorded as a reduction of Inventory on the Consolidated Balance Sheets. Three months ended Six months ended 2024 2023 2024 2023 Opening balance $ 6,622 $ 6,953 $ 6,593 $ 6,759 Liabilities for warranties and product repair costs accrued during the period 1,023 723 2,356 2,025 Warranty claims settled and product repair costs expended during the period ( 1,294 ) ( 1,009 ) ( 2,598 ) ( 2,117 ) Ending balance $ 6,351 $ 6,667 $ 6,351 $ 6,667

Restructuring Expenses

Restructuring Expenses	6 Months Ended
Restructuring Expenses	Aug. 31, 2024
Restructuring and Related Activities [Abstract]
Restructuring Expenses	(17) Restructuring Expenses The Company records liabilities for costs associated with exit or disposal activities in the period in which the liability is incurred. Employee severance costs are accrued when the restructuring actions are probable and estimable. Costs for one-time termination benefits in which the employee is required to render service until termination in order to receive the benefits are recognized ratably over the future service period. During the second quarter of Fiscal 2023, the Company began moving certain of its OEM production operations from Florida to Mexico, which is expected to be completed during Fiscal 2025. During the second quarters of Fiscal 2024 and Fiscal 2025, the Company implemented cost reduction initiatives in order to streamline operations, reduce costs, and align its business in response to market conditions. As a result of these initiatives, the Company incurred restructuring expenses, consisting primarily of employee severance and relocation expenditures, of $ 2,098 and $ 2,329 , and $ 2,008 and $ 2,067 for the three and six months ended August 31, 2024 and 2023, respectively. For the three and six months ended August 31, 2024 , we incurred restructuring charges within the Automotive Electronics segment of $ 156 and $ 393 , respectively, and within the Consumer Electronics segment of $ 1,943 and $ 1,935 , respectively. For the three and six months ended August 31, 2023 we incurred restructuring charges within the Automotive Electronics segment of $ 726 and $ 785 , respectively, as well as $ 1,077 in the Consumer Electronics segment, $ 27 in the Biometrics segment, and $ 177 in Corporate. At August 31, 2024 , the balance of restructuring charges not yet settled was $ 1,375 and are included within Accrued expenses and other current liabilities on the Company's Consolidated Balance Sheet. The Company expects substantially all of this liability balance to be settled during Fiscal 2025. Additional restructuring charges related to relocation and cost reductions may be incurred during Fiscal 2025 .

Financing Arrangements

Financing Arrangements	6 Months Ended
Financing Arrangements	Aug. 31, 2024
Debt Disclosure [Abstract]
Financing Arrangements	(18) Financing Arrangements The Company has the following financing arrangements: August 31, February 29, Debt Domestic credit facility (a) $ 45,832 $ 63,843 Florida mortgage (b) 5,365 5,615 Euro asset-based lending obligation - VOXX Germany (c) - - Shareholder loan payable (d) 3,970 3,813 Total debt 55,167 73,271 Less: current portion of long-term debt 4,469 500 Long-term debt 50,698 72,771 Less: debt issuance costs 683 890 Total long-term debt, net of debt issuance costs $ 50,015 $ 71,881 (a) Domestic Credit Facility The Company has a senior secured credit facility (the "Credit Facility") with Wells Fargo Bank, N.A. ("Wells Fargo") that provides for a revolving credit facility with committed availability of up to $ 165,000 . The Credit Facility also includes a $ 50,000 sub-limit for letters of credit and a $ 15,000 sub-limit for Swing Loans. The availability under the revolving credit line within the Credit Facility is subject to a borrowing base, which is based on eligible accounts receivable, eligible inventory, certain real estate, and certain intellectual property, subject to reserves as determined by the lender, and is also limited by amounts outstanding under the Florida Mortgage (see Note 18(b)). The availability under the revolving credit line of the Credit Facility was $ 62,275 as of August 31, 2024. All amounts outstanding under the Credit Facility will mature and become due on April 19, 2026 ; however, it is subject to acceleration upon the occurrence of an Event of Default as defined in the Second Amended and Restated Credit Agreement (“the Agreement”). The Company may prepay any amounts outstanding at any time. The commitments under the Credit Facility may be irrevocably reduced at any time, without premium or penalty as set forth in the Agreement. Generally, the Company may designate specific borrowings under the Credit Facility as either Base Rate Loans or SOFR Rate Loans, except that Swing Loans may only be designated as Base Rate Loans. Loans designated as SOFR Rate Loans bear interest at a rate equal to the then applicable SOFR rate plus a range of 1.75 – 2.25 % ( 7.43 % at August 31, 2024 ). Loans designated as Base Rate loans bear interest at a rate equal to the applicable margin for Base Rate Loans plus a range of 0.75 - 1.25 % as defined in the Agreement and shall not be lower than 1.75 % ( 9.50 % at August 31, 2024). Provided that the Company is in a Compliance Period (the period commencing on that day in which Excess Availability is less than 15 % of the Maximum Revolver Amount and ending on a day in which Excess Availability is equal to or greater than 15% for any consecutive 30-day period thereafter) , the Credit Facility requires compliance with a financial covenant calculated as of the last day of each month, consisting of a Fixed Charge Coverage Ratio. The Credit Facility also contains covenants, subject to defined carveouts, that limit the ability of the loan parties and certain of their subsidiaries which are not loan parties to, among other things: (i) incur additional indebtedness; (ii) incur liens; (iii) merge, consolidate or dispose of a substantial portion of their business; (iv) transfer or dispose of assets; (v) change their name, organizational identification number, state or province of organization or organizational identity; (vi) make any material change in their nature of business; (vii) prepay or otherwise acquire indebtedness; (viii) cause any change of control; (ix) make any restricted junior payment, including the declaration of dividends; (x) change their fiscal year or method of accounting; (xi) make advances, loans or investments; (xii) enter into or permit any transaction with an affiliate of any borrower or any of their subsidiaries; (xiii) use proceeds for certain items; (xiv) issue or sell any of their stock; or (xv) consign or sell any of their inventory on certain terms. In addition, if excess availability under the Credit Facility were to fall below certain specified levels, as defined in the Agreement, the lenders would have the right to assume dominion and control over the Company's cash. As of August 31, 2024, the Company was not in a Compliance Period. The obligations under the Credit Facility documents are secured by a general lien on, and security interest in, substantially all of the assets of the borrowers and certain of the guarantors, including accounts receivable, equipment, real estate, general intangibles, and inventory. The Company, as parent, has guaranteed the obligations of its subsidiary borrowers under the Agreement. Charges incurred on the unused portion of the Credit Facility during the three and six months ended August 31, 2024 totaled $ 164 and $ 311 , respectively, compared to $ 199 and $ 405 during the three and six months ended August 31, 2023, respectively. These charges are included within Interest and bank charges on the Unaudited Consolidated Statements of Operations and Comprehensive Income (Loss). The Company has deferred financing costs related to the Credit Facility and previous amendments and modifications of the Credit Facility. Deferred financing costs are included in Long-term debt on the accompanying Consolidated Balance Sheets as a contra-liability balance and are amortized through Interest and bank charges in the Unaudited Consolidated Statements of Operations and Comprehensive Income (Loss) over the term of the Credit Facility, which expires on April 19, 2026 . During the three and six months ended August 31, 2024, the Company amortized $ 92 and $ 184 of these costs, respectively, as compared to $ 89 and $ 176 during the three and six months ended August 31, 2023, respectively. The net unamortized balance of these deferred financing costs as of August 31, 2024 was $ 615 . (b) Florida Mortgage On July 6, 2015, VOXX HQ LLC, the Company’s wholly owned subsidiary, closed on a $ 9,995 industrial development revenue tax exempt bond under a loan agreement in favor of the Orange County Industrial Development Authority (the “Authority”) to finance the construction of the Company's manufacturing facility and executive offices in Lake Nona, Florida. Wells Fargo Bank, N.A. ("Wells Fargo") was the purchaser of the bond and U.S. Bank National Association is the trustee under an Indenture of Trust with the Authority. Voxx borrowed the proceeds of the bond purchase from the Authority during construction as a revolving loan, which converted to a permanent mortgage upon completion of the facility in January 2016 (the "Florida Mortgage"). The Company makes principal and interest payments to Wells Fargo, which began March 1, 2016 and will continue through March of 2026. The Florida Mortgage bears interest at 79 % of the applicable SOFR Rate plus 1.87 % ( 7.19 % at August 31, 2024) and is secured by a first mortgage on the property, a collateral assignment of leases and rents and a guaranty by the Company. The financial covenants of the Florida Mortgage are as defined in the Company’s Credit Facility with Wells Fargo dated April 26, 2016 and amended in April 2021 and February 2023. The Company is in compliance with the financial covenants of the Florida Mortgage, which are as defined in the Company’s Credit Facility with Wells Fargo dated April 26, 2016, as amended (see Note 27). The Company has deferred financing costs related to the Florida Mortgage and a previous amendment to the loan agreement, which are recorded as deferred financing costs and included in Long-term debt as a contra-liability balance on the accompanying Consolidated Balance Sheets and are being amortized through Interest and bank charges in the Unaudited Consolidated Statements of Operations and Comprehensive Income (Loss) over the remaining term of the Florida Mortgage. The Company amortized $ 11 and $ 22 of these costs during the three and six months ended August 31, 2024, respectively, as compared to $ 11 and $ 20 during the three and six months ended August 31, 2023. The net unamortized balance of these deferred financing costs as of August 31, 2024 is $ 68 . The Company has an interest rate swap agreement to hedge interest rate exposure related to the Florida Mortgage. The swap contract has a set fixed rate equal to 3.43 % (see Note 6 and Note 27). (c) Euro Asset-Based Lending Obligation – VOXX Germany Foreign bank obligations include a Euro Asset-Based Lending ("ABL") credit facility, which has a credit limit of € 8,000 for the Company's subsidiary, VOXX Germany, which expires on October 31, 2024. T he rate of interest for the ABL is the three-month Euribor plus 3.55 % ( 7.04 % at August 31, 2024 ). (d) Shareholder Loan Payable In conjunction with the capitalization and funding of the Company’s Onkyo joint venture, which was created in order to execute the acquisition of certain assets of the home audio/video business of OHEC on September 8, 2021, Onkyo entered into a loan agreement with the shareholders of the joint venture. The loan balance outstanding at August 31, 2024 represents the portion of the loan payable to PAC's joint venture partner. The loan balance due to PAC eliminates in consolidation. All amounts outstanding under the loan will mature and become payable ten years from the execution date of the acquisition, which is September 8, 2031. The loan may be prepaid subject to the approval of the board of directors of the joint venture and must be repaid if either the put or call option is exercised in accordance with the joint venture agreement (see Note 3). The rate of interest for the shareholder loan is 2.5 % and the loan is secured by a second priority lien on and secured interest in all assets of Onkyo.

Other Income (Expense)

Other Income (Expense)	6 Months Ended
Other Income (Expense)	Aug. 31, 2024
Other Income and Expenses [Abstract]
Other Income (Expense)	(19) Other Income (Expense) Other income (expense) is comprised of the following: Three months ended Six months ended 2024 2023 2024 2023 Foreign currency gain (loss), net $ 3,204 $ ( 1,261 ) $ 1,353 $ ( 2,248 ) Interest income 75 16 171 33 Rental income 262 236 522 465 Miscellaneous 301 57 ( 75 ) 97 Total other, net $ 3,842 $ ( 952 ) $ 1,971 $ ( 1,653 ) Gains and losses included within Foreign currency gain (loss), net, for the three and six months ended August 31, 2024 and 2023 were primarily driven by fluctuations in the Japanese Yen, which impacted the re-measurement of the Company's Onkyo subsidiary intercompany loans and interest payable, which are not of a long-term investment nature. The total foreign currency gain (loss) attributable to these re-measurements for the three and six months ended August 31, 2024 was $ 1,915 and $ 779 , as compared to $( 892 ) and $( 1,347 ) for the three and six months ended August 31, 2023 , respectively.

Lease Obligations

Lease Obligations	6 Months Ended
Lease Obligations	Aug. 31, 2024
Leases [Abstract]
Lease Obligations	(20) Lease Obligations We account for leases in accordance with ASC 842 “Leases” (“ASC 842”). We determine whether an arrangement is a lease at inception. This determination generally depends on whether the arrangement conveys the right to control the use of an identified fixed asset explicitly or implicitly for a period of time in exchange for consideration. We have operating leases for office equipment, as well as offices, warehouses, and other facilities used for our operations. We also have finance leases comprised primarily of computer hardware. Our leases have remaining lease terms of less than 1 year to 7 years , some of which include renewal options. We consider these renewal options in determining the lease term used to establish our right-of-use assets and lease liabilities when it is determined that it is reasonably certain that the renewal option will be exercised. The Company had no short-term leases during the three and six months ended August 31, 2024. Refer to Note 8 for supplemental cash flow information related to leases. The components of lease cost for the three and six months ended August 31, 2024 and 2023 were as follows: Three months ended Six months ended 2024 2023 2024 2023 Operating lease cost (a) (c) $ 318 $ 338 $ 631 $ 703 Finance lease cost: Amortization of right of use assets (a) 109 100 218 169 Interest on lease liabilities (b) 18 7 30 8 Total finance lease cost $ 127 $ 107 248 $ 177 (a) Recorded within Selling, General and administrative, Engineering and technical support, and Cost of sales on the Unaudited Consolidated Statements of Operations and Comprehensive Income (Loss) . (b) Recorded within Interest and bank charges on the Unaudited Consolidated Statements of Operations and Comprehensive Income (Loss) . (c) Includes immaterial amounts related to variable rent expense. Supplemental balance sheet information related to leases is as follows: August 31, 2024 February 29, 2024 Operating Leases Operating lease, right of use assets $ 2,815 $ 2,577 Total operating lease right of use assets $ 2,815 $ 2,577 Accrued expenses and other current liabilities $ 1,017 $ 782 Operating lease liabilities, less current portion 1,917 1,884 Total operating lease liabilities $ 2,934 $ 2,666 Finance Leases Property, plant, and equipment, gross 3,835 $ 3,835 Accumulated depreciation ( 3,081 ) ( 2,863 ) Total finance lease right of use assets 754 $ 972 Accrued expenses and other current liabilities $ 305 $ 349 Finance lease liabilities, less current portion 484 644 Total finance lease liabilities $ 789 $ 993 Weighted Average Remaining Lease Term Operating leases 4.2 years 4.9 years Finance leases 2.9 years 3.1 years Weighted Average Discount Rate Operating leases 4.74 % 4.12 % Finance leases 7.05 % 8.45 % Maturities of lease liabilities on August 31 of each of the succeeding years are as follows: Operating Leases Finance Leases 2025 $ 1,104 366 2026 747 299 2027 381 111 2028 257 111 2029 250 9 Thereafter 431 - Total lease payments 3,170 896 Less imputed interest 236 107 Total $ 2,934 789 As of August 31, 2024, the Company has not entered into any lease agreements that have not yet commenced. The Company owns and occupies buildings as part of its operations. Certain space within these buildings may, from time to time, be leased to third parties from which the Company earns rental income as lessor. This leased space is recorded within property, plant, and equipment and was not material to the Company's Consolidated Balance Sheets at August 31, 2024 and February 29, 2024. Rental income earned by the Company for the three and six months ended August 31, 2024 and 2023 was $ 262 and $ 522 , respectively, as compared to $ 236 and $ 465 , respectively, and is recorded within Other income (expense).

Capital Structure

Capital Structure	6 Months Ended
Capital Structure	Aug. 31, 2024
Equity [Abstract]
Capital Structure	(21) Capital Structure The Company's capital structure is as follows: Shares Authorized Shares Outstanding Security Par August 31, 2024 February 29, 2024 August 31, 2024 February 29, 2024 Voting Liquidation Preferred Stock $ 50.00 50,000 50,000 - - - $ 50 per share Series Preferred Stock $ 0.01 1,500,000 1,500,000 - - - — Class A Common Stock $ 0.01 60,000,000 60,000,000 19,647,196 19,698,562 1 Ratably with Class B Common Stock $ 0.01 10,000,000 10,000,000 2,260,954 2,260,954 10 Ratably with Treasury Stock at cost at cost 4,351,183 4,287,041 N/A N/A N/A The Company's Class A common shares outstanding are presented net of 597,021 and 577,581 shares subject to possible redemption at August 31, 2024 and February 29, 2024, respectively (see Note 9). During the six months ended August 31, 2024, the Company repurchased 64,142 shares of Class A common stock, for an aggregate cost of $ 248 . As of August 31, 2024, 816,911 shares of the Company’s Class A common stock are authorized to be repurchased in the open market.

Variable Interest Entity

Variable Interest Entity	6 Months Ended
Variable Interest Entity	Aug. 31, 2024
Variable Interest Entity [Abstract]
Variable Interest Entity	(22) Variable Interest Entity A variable interest entity ("VIE") is an entity that either (i) has insufficient equity to permit the entity to finance its activities without additional subordinated financial support, or (ii) has equity investors who lack the characteristics of a controlling financial interest. Under ASC 810 – “Consolidation,” an entity that holds a variable interest in a VIE and meets certain requirements would be considered to be the primary beneficiary of the VIE and required to consolidate the VIE in its consolidated financial statements. In order to be considered the primary beneficiary of a VIE, an entity must hold a variable interest in the VIE and have both: • the power to direct the activities that most significantly impact the economic performance of the VIE; and • the right to receive benefits from, or the obligation to absorb losses of, the VIE that could be potentially significant to the VIE. On September 1, 2015, Voxx acquired a majority voting interest in substantially all of the assets and certain specified liabilities of EyeLock, Inc. and EyeLock Corporation, a market leader of iris-based identity authentication solutions, through a newly formed entity, EyeLock LLC. The Company issued EyeLock LLC a promissory note for the purposes of repaying protective advances and funding working capital requirements of the entity. On August 25, 2022, this promissory note was amended and restated to allow EyeLock LLC to borrow up to $ 71,200 . Through March 1, 2019, interest on the outstanding principal of the loan accrued at 10 %. From March 1, 2019 forward, interest accrues at 2.5 %. The amended and restated promissory note is due on February 28, 2025. The outstanding principal balance of this promissory note is convertible at the sole option of Voxx into units of EyeLock LLC. If Voxx chooses not to convert into equity, the outstanding loan principal of the amended and restated promissory note will be repaid at a multiple of 1.50 based on the repayment date. The agreement includes customary events of default and is collateralized by all of the property of EyeLock LLC. We determined that we hold a variable interest in EyeLock LLC as a result of: • our majority voting interest and ownership of substantially all of the assets and certain liabilities of the entity; and • the loan agreement with EyeLock LLC, which has a total outstanding balance of $ 69,301 as of August 31, 2024. We concluded that we became the primary beneficiary of EyeLock LLC on September 1, 2015 in conjunction with the acquisition. This was the first date on which we had the power to direct the activities that most significantly impact the economic performance of the entity because we acquired a majority interest in substantially all of the assets and certain liabilities of EyeLock, Inc. and EyeLock Corporation on this date, as well as obtained a majority voting interest as a result of this transaction. Although we are considered to have control over EyeLock LLC under ASC 810, due to our majority ownership interest, the assets of EyeLock LLC can only be used to satisfy the obligations of EyeLock LLC. As a result of our majority ownership interest in the entity and our primary beneficiary conclusion, we consolidated EyeLock LLC within our consolidated financial statements beginning on September 1, 2015. On April 29, 2021, EyeLock LLC entered into a three-year exclusive distribution agreement (the “Distribution Agreement”) with GalvanEyes LLC (“GalvanEyes”), a Florida LLC managed by Beat Kahli, the Vice Chairman of Voxx's Board of Directors. The Distribution Agreement provided that GalvanEyes would be the exclusive distributor of EyeLock products in the European Union, Switzerland, Puerto Rico, Malaysia, and Singapore, with the exception of any existing customer relationships prior to the Distribution Agreement date. The Distribution Agreement also included a put/call arrangement, whereby GalvanEyes had the right to put the exclusivity back to EyeLock after the initial two-year period for a 20.0 % interest in EyeLock. In turn, EyeLock had the ability to call the exclusivity during the term of the Distribution Agreement, based on the occurrence of certain events, which would result in a 20.0 % equity interest given to GalvanEyes. Under the Distribution Agreement, in addition to paying for any products purchased, GalvanEyes agreed to pay EyeLock $ 10,000 in the form of an annual fee, over a two-year period, of up to $ 5,000 per year, with payments on a quarterly basis beginning on September 1, 2021. As of February 29, 2024, q uarterly installment payments due from GalvanEyes under the Distribution Agreement were past due and totaled $ 2,578 . A promissory note was signed by GalvanEyes on March 1, 2024 for the repayment of the remaining quarterly installments payable. The balance will be paid in eight quarterly installments beginning May 31, 2024 and ending on February 28, 2026 with interest accruing at a rate of 8 %. The balance due under the promissory note at August 31, 2024 , including accrued interest, totaled $ 2,323 . A payment was received for the second quarterly promissory note installment in the amount of $ 352 on September 3, 2024. On March 1, 2024, EyeLock LLC entered into a joint venture agreement (the "JV Agreement") with GalvanEyes to engage in a newly formed entity, BioCenturion LLC, to operate a biometrics business (see Note 13). EyeLock contributed assets, including all of its inventory and intangible assets, to the joint venture. Beat Kahli will serve as Chairman of the Board and Chief Executive Officer of BioCenturion LLC. Simultaneously with the formation of the joint venture and execution of the JV Agreement, the Distribution Agreement was terminated. The put option established by the Distribution Agreement was canceled and the liability of $ 9,817 on the Company's Consolidated Balance Sheet at February 29, 2024, representing the prepayment made by GalvanEyes of a 20.0 % interest in EyeLock upon exercise of the put option, was reclassified to Additional paid in capital and Non-controlling interest in proportion to the Company's ownership interest in EyeLock. The balance due on the promissory note receivable from GalvanEyes was also reclassified to Additional paid in capital, representing a contra-equity balance until the note is repaid. The Company has concluded that BioCenturion is a variable interest entity for which EyeLock lacks the power to direct the activities that most significantly impact the joint venture's economic performance. As EyeLock is not the primary beneficiary, it does not consolidate the variable interest entity. Assets and Liabilities of EyeLock LLC The following table sets forth the carrying values of assets and liabilities of EyeLock LLC that were included on our Consolidated Balance Sheets as of August 31, 2024 and February 29, 2024: August 31, February 29, Assets (unaudited) Current assets: Cash and cash equivalents $ 4 $ - Accounts receivable, net ( 25 ) 64 Inventory, net - 1,839 Due from GalvanEyes LLC , current - 1,238 Prepaid expenses and other current assets - 58 Total current assets ( 21 ) 3,199 Equity investment 1,625 - Property, plant and equipment, net - 4 Intangible assets, net - 1,514 Due from GalvanEyes LLC , less current portion - 1,340 Other assets - 5 Total assets $ 1,604 $ 6,062 Liabilities and Partners' Deficit Current liabilities: Accounts payable $ 769 $ 759 Interest payable to VOXX 17,416 16,525 Accrued expenses and other current liabilities 107 287 Due to VOXX 69,301 69,377 Total current liabilities 87,593 86,948 Prepaid ownership interest in EyeLock LLC due to GalvanEyes LLC - 9,817 Other long-term liabilities 1,200 1,200 Total liabilities 88,793 97,965 Commitments and contingencies Partners' deficit: Capital 48,496 41,416 Retained losses ( 135,685 ) ( 133,319 ) Total partners' deficit ( 87,189 ) ( 91,903 ) Total liabilities and partners' deficit $ 1,604 $ 6,062 Revenues and Expenses of EyeLock LLC The following table sets forth the revenues and expenses of EyeLock LLC that were included in our Unaudited Consolidated Statements of Operations and Comprehensive Income (Loss) for the three and six months ended August 31, 2024 and 2023: For the three months For the six months 2024 2023 2024 2023 Net sales - $ 210 $ 8 $ 310 Cost of sales 139 153 139 205 Gross profit ( 139 ) 57 ( 131 ) 105 Operating expenses: Selling ( 10 ) 28 ( 9 ) 217 General and administrative ( 4 ) 449 33 888 Engineering and technical support ( 6 ) 563 ( 19 ) 1,221 Total operating expenses ( 20 ) 1,040 5 2,326 Operating loss ( 119 ) ( 983 ) ( 136 ) ( 2,221 ) Other expense: Interest and bank charges ( 448 ) ( 433 ) ( 899 ) ( 861 ) Equity in loss of equity investee ( 601 ) - ( 1,365 ) - Other, net 397 - 34 - Total other expense, net ( 652 ) ( 433 ) ( 2,230 ) ( 861 ) Loss before income taxes ( 771 ) ( 1,416 ) ( 2,366 ) ( 3,082 ) Income tax expense - - - - Net loss $ ( 771 ) $ ( 1,416 ) $ ( 2,366 ) $ ( 3,082 )

Segment Reporting

Segment Reporting	6 Months Ended
Segment Reporting	Aug. 31, 2024
Segment Reporting [Abstract]
Segment Reporting	(23) Segment Reporting The Company operates in three distinct segments based on our products and our internal organizational structure. The three operating segments, which are also the Company’s reportable segments, are Automotive Electronics, Consumer Electronics, and Biometrics. Our Automotive Electronics segment designs, manufactures, distributes and markets automotive security, vehicle access, and remote start modules and systems; smart phone telematics applications; mobile multi-media infotainment products and rear-seat entertainment products, including overhead, seat-back, and headrest systems; rear observation and collision avoidance systems; blind spot sensors; automotive sensing and camera systems; driver distraction products; 360 camera applications; distribution of satellite radios, including plug and play models and direct connect models; cruise control systems; private label audio products; heated seats; interior lighting solutions; security and shock sensors; turn signal switches; puddle lamps; box lights; harnesses; Electric Vehicle Sound Systems ("EVSS"); interior lighting systems; and logo lighting modules. Our Consumer Electronics segment designs, manufactures, distributes and markets premium loudspeakers; architectural speakers; commercial and cinema speakers; outdoor speakers; wireless and Bluetooth speakers; A/V receivers; high performance 2 channel loudspeakers; high performance 2 channel electronics; high performance party speakers; home theater systems; business music systems; streaming music systems; on-ear and in-ear headphones; wired and wireless headphones and ear buds; Bluetooth headphones and ear buds; soundbars; solar powered balcony systems; High-Definition Television ("HDTV") antennas; Wireless Fidelity ("WiFi") antennas; High-Definition Multimedia Interface ("HDMI") accessories; karaoke products; home electronic accessories such as cabling, power cords, and other connectivity products; performance enhancing electronics; power supply systems and charging products; electronic equipment cleaning products; set-top boxes; and home and portable stereos. Our Biometrics segment consists of an equity investment in BioCenturion LLC (see Note 13) which designs, manufactures, markets, and distributes iris identification and biometric security related products. The accounting principles applied at the consolidated financial statement level are generally the same as those applied at the operating segment level and intersegment sales are not material. The segments are allocated interest expense, based upon a pre-determined formula, which utilizes a percentage of each operating segment's intercompany balance, which is offset in Corporate/Eliminations. Segment data for each of the Company's segments is presented below: Automotive Consumer Biometrics (a) Corporate/ Total Three Months Ended August 31, 2024 Net sales $ 26,381 $ 66,058 - $ 49 $ 92,488 Equity in income of equity investees (a) 801 - ( 601 ) - 200 Interest expense and bank charges 359 1,677 448 ( 511 ) 1,973 Depreciation and amortization expense 746 1,475 - 644 2,865 (Loss) income before income taxes (a) (b) ( 1,812 ) 5,933 ( 770 ) 41 3,392 Three Months Ended August 31, 2023 Net sales $ 35,417 $ 78,044 $ 209 $ ( 28 ) $ 113,642 Equity in income of equity investees 1,241 - - - 1,241 Interest expense and bank charges 493 2,002 433 ( 1,355 ) 1,573 Depreciation and amortization expense 818 1,491 70 866 3,245 Loss before income taxes ( 622 ) ( 3,208 ) ( 1,416 ) ( 6,161 ) ( 11,407 ) Six Months Ended August 31, 2024 Net sales $ 54,066 $ 129,976 $ 8 $ 99 $ 184,149 Equity in income (loss) of equity investees (a) 1,916 - ( 1,365 ) - 551 Interest expense and bank charges 770 3,494 899 ( 1,052 ) 4,111 Depreciation and amortization expense 1,489 2,946 - 1,294 5,729 (Loss) income before income taxes (a) (b) ( 3,628 ) 4,609 ( 2,365 ) ( 5,995 ) ( 7,379 ) Six Months Ended August 31, 2023 Net sales $ 73,829 $ 151,374 $ 309 $ 56 $ 225,568 Equity in income of equity investees 2,857 - - - 2,857 Interest expense and bank charges 1,044 4,066 861 ( 2,852 ) 3,119 Depreciation and amortization expense 1,698 2,954 140 1,700 6,492 Loss before income taxes ( 1,900 ) ( 6,967 ) ( 3,082 ) ( 12,484 ) ( 24,433 ) (a) On March 1, 2024, the Company's majority owned subsidiary, EyeLock LLC, contributed assets, including inventory and intangible assets, to a newly formed joint venture, BioCenturion LLC, which will operate a Biometrics business. For the three and six months ended August 31, 2024 , the Company accounted for its investment in BioCenturion LLC as an equity method investment (see Note 12). (b) Included in Income before taxes within the Consumer Electronics segment for the three and six months ended August 31, 2024 is a gain on the sale of a business in the amount of $ 8,300 and a gain on the sale of assets in the amount of $ 2,154 (see Note 2).

Revenue from Contracts with Cus

Revenue from Contracts with Customers	6 Months Ended
Revenue from Contracts with Customers	Aug. 31, 2024
Revenue from Contract with Customer [Abstract]
Revenue from Contracts with Customers	(24) Revenue from Contracts with Customers The Company recognizes revenue in accordance with ASC Topic 606, “Revenue from Contracts with Customers” (“ASC 606”). The core principle of ASC 606 is that an entity recognizes revenue to depict the transfer of promised goods and services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods and services. We apply the FASB’s guidance on revenue recognition, which requires us to recognize the amount of revenue and consideration that we expect to receive in exchange for goods and services transferred to our customers. To do this, the Company applies the five-step model prescribed by the FASB, which requires us to: (i) identify the contract with the customer; (ii) identify the performance obligations in the contract; (iii) determine the transaction price; (iv) allocate the transaction price to the performance obligations in the contract; and (v) recognize revenue when, or as, we satisfy a performance obligation. Within our Automotive Electronics segment, while the majority of the contracts we enter into with Original Equipment Manufacturers (“OEMs”) are long-term supply arrangements, the performance obligations are established by the enforceable contract, which is generally considered to be the purchase order. The purchase orders are of durations less than one year. As such, the Company applies the practical expedient in ASC paragraph 606-10-50-14 and does not disclose information about remaining performance obligations that have original expected durations of one year or less for which work has not yet been performed. Performance Obligations The Company’s primary source of revenue is derived from the manufacture and distribution of consumer electronic and automotive electronic products. Our consumer electronic products are primarily comprised of finished goods sold to retail and commercial customers, consisting of premium audio products and other consumer electronic products. Our automotive electronic products, some of which are manufactured by the Company, are sold both to OEM and aftermarket customers. We recognize revenue for sales to our customers when transfer of control of the related good or service has occurred. Our revenue was predominantly recognized under the point in time approach for the three and six months ended August 31, 2024 and 2023. Certain telematic subscription revenues generated by our Automotive Electronics segment are recognized over time. Contract terms with certain of our OEM customers could result in additional products and services being transferred over time as a result of the customized nature of some of our products, together with contractual provisions in the customer contracts that provide us with an enforceable right to payment for performance completed to date; however, under typical terms, we do not have the right to consideration until the time of shipment from our manufacturing facilities or distribution centers, or until the time of delivery to our customers. If certain contracts in the future provide the Company with this enforceable right of payment, the timing of revenue recognition from products transferred to customers over time may be slightly accelerated compared to our right to consideration at the time of shipment or delivery. Under ASC 606, we are required to present a refund liability and a return asset within the Consolidated Balance Sheets. The changes in the refund liability are reported in Net sales, and the changes in the return asset are reported in Cost of sales in the Unaudited Consolidated Statements of Operations and Comprehensive Income (Loss). As of August 31, 2024 and February 29, 2024, the balance of the return asset was $ 995 and $ 1,683, respectively, and the balance of the refund liability was $ 1,769 and $ 3,648 , respectively, and are presented within Prepaid expenses and other current assets and Accrued expenses and other current liabilities, respectively, on the Consolidated Balance Sheets. We warrant our products against certain defects in material and workmanship when used as designed, which primarily range from 30 days to 3 years. We offer limited lifetime warranties on certain products, which limit the customer’s remedy to the repair or replacement of the defective product or part for the designated lifetime of the product, or for the life of the vehicle for the original owner, if it is an automotive product. Contract Balances Contract assets primarily relate to the Company’s rights to consideration for work completed but not billed at the reporting date on contracts with customers. Contract assets are transferred to receivables when the rights become unconditional. Contract liabilities primarily relate to contracts where advance payments or deposits have been received, but performance obligations have not yet been met, and therefore, revenue has not been recognized. The Company had current and non-current contract liability balances totaling $ 3,836 at August 31, 2024 related to telematic subscription services. The following table provides a reconciliation of the Company’s contract liabilities as of August 31, 2024: Balance at February 29, 2024 $ 4,419 Subscription payments received 2,777 Revenue recognized ( 3,360 ) Balance at August 31, 2024 $ 3,836 $ 3,265 of the contract liability balance at August 31, 2024 will be recognized during the next twelve months. The Company had no contract asset balances at August 31, 2024 or February 29, 2024. Disaggregation of Revenue The Company operates in three reportable segments: Automotive Electronics, Consumer Electronics, and Biometrics. ASC 606 requires further disaggregation of an entity’s revenue. In the following table, the Company's net sales are disaggregated by segment and product type for the three and six months ended August 31, 2024 and 2023: Three months ended Six months ended 2024 2023 2024 2023 Automotive Electronics Segment OEM Products $ 11,013 $ 16,252 $ 23,852 $ 36,535 Aftermarket Products 15,368 19,165 30,214 37,294 Total Automotive Segment 26,381 35,417 54,066 73,829 Consumer Electronics Segment Premium Audio Products 49,926 53,199 98,308 100,803 Other Consumer Electronic Products 16,132 24,845 31,668 50,571 Total Consumer Electronics Segment 66,058 78,044 129,976 151,374 Biometrics Segment Biometric Products (a) - 209 8 309 Total Biometrics Segment - 209 8 309 Corporate/Eliminations 49 ( 28 ) 99 56 Total Net Sales $ 92,488 $ 113,642 $ 184,149 $ 225,568 (a) On March 1, 2024, the Company's majority owned subsidiary, EyeLock LLC, contributed assets, including inventory and intangible assets, to a newly formed joint venture, BioCenturion LLC, that will operate a Biometrics business. For the three and six months ended August 31, 2024 , the Company accounted for its investment in BioCenturion LLC as an equity method investment (see Note 13).

Contingencies

Contingencies	6 Months Ended
Contingencies	Aug. 31, 2024
Commitments and Contingencies Disclosure [Abstract]
Contingencies	(25) Contingencies The Company is currently, and has in the past, been a party to various routine legal proceedings incident to the ordinary course of business. If management determines, based on the underlying facts and circumstances of each matter, that it is probable a loss will result from a litigation contingency and the amount of the loss can be reasonably estimated, the estimated loss is accrued for. The products the Company sells are continually changing as a result of improved technology. As a result, although the Company and its suppliers attempt to avoid infringing known proprietary rights, the Company may be subject to legal proceedings and claims for alleged infringement by patent, trademark, or other intellectual property owners. Any claims relating to the infringement of third-party proprietary rights, even if not meritorious, could result in costly litigation, divert management’s attention and resources, or require the Company to either enter into royalty or license agreements that are not advantageous to the Company, or pay material amounts of damages.

New Accounting Pronouncements

New Accounting Pronouncements	6 Months Ended
New Accounting Pronouncements	Aug. 31, 2024
Accounting Changes and Error Corrections [Abstract]
New Accounting Pronouncements	(26) New Accounting Pronouncements In August 2023, the FASB issued ASU No. 2023-05, "Business Combinations - Joint Venture Formations (Subtopic 805-60): Recognition and Initial Measurement." The update provides guidance requiring a joint venture to initially measure all contributions received upon its formation at fair value, largely consistent with ASC 805, Business Combinations. The guidance is intended to reduce diversity in practice and provide users of joint venture financial statements with more decision-useful information. ASC 2023-05 should be applied prospectively and is effective for all newly formed joint venture entities with a formation date on or after January 1, 2025. Early adoption is permitted, and joint ventures formed prior to the adoption date may elect to apply the new guidance retrospectively back to their original formation date. The Company is currently evaluating the impact this update may have on its consolidated financial statements. In October 2023, the FASB issued ASU No. 2023-06, "Disclosure Improvements." The new guidance clarifies or improves disclosure and presentation requirements on a variety of topics in the codification. The amendments will align the requirements in the FASB Accounting Standard Codification with the SEC’s regulations. The amendments are effective prospectively on the date each individual amendment is effectively removed from Regulation S-X or Regulation S-K. The Company is in the process of evaluating the impact the adoption of this ASU will have on the financial statements and related disclosures, which is not expected to be material. In November 2023, the FASB issued ASU No. 2023-07, "Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures." The new guidance is intended to improve reportable segment disclosure requirements primarily through enhanced disclosures about significant segment expenses. The amendment is effective retrospectively for fiscal years beginning after December 15, 2023 and interim periods within fiscal years beginning after December 15, 2024. The Company is in the process of evaluating the impact that the adoption ASU No. 2023-07 will have to the financial statements and related disclosures. In December 2023, the FASB issued ASU No. 2023-09, "Income Taxes (Topic 740): Improvements to Income Tax Disclosures." The new guidance is intended to enhance the transparency and decision usefulness of income tax disclosures. The amendments in the ASU address investor requests for enhanced income tax information primarily through changes to the rate reconciliation and income taxes paid information. The amendment is effective retrospectively for fiscal years beginning after December 15, 2024, on a prospective basis, with early adoption permitted. The Company is in the process of evaluating the impact that the adoption ASU No. 2023-09 will have to the financial statements and related disclosures. In March 2024, the Securities and Exchange Commission ("SEC") issued Final Rule No. 33-11275, "The Enhancement and Standardization of Climate-Related Disclosures for Investors." If such rule remains in effect, the rule will require registrants to provide climate related disclosures in their annual reports, including, but not limited to, material Scope 1 and Scope 2 GHG emissions (for large accelerated filers and accelerated filers); governance and oversight of material climate-related risks; the material impact of climate risks on the registrant’s strategy, business model, and outlook; risk management processes for material climate-related risks; and material climate targets and goals. Based on our current accelerated filer status, certain elements of the rule would be effective for our fiscal year ending February 28, 2027, with the remaining disclosure requirements effective for our fiscal years ending February 29, 2028 and February 28, 2029. In April 2024, the SEC issued an order staying implementation of such rule pending the resolution of certain challenges. The outcome of ongoing litigation is currently unknown. The Company is currently evaluating the potential impact of such rule on its consolidated financial statements and disclosures.

Subsequent Event

Subsequent Event	6 Months Ended
Subsequent Event	Aug. 31, 2024
Subsequent Events [Abstract]
Subsequent Event	(27) Subsequent Event On September 24, 2024, the Company completed the sale of its manufacturing facility in Lake Nona, Florida to Aladdin Sane Realty, LLC (the "buyer") for a purchase price of $ 20,000 . Net proceeds from the sale were used to repay the remaining outstanding balance of the Company's Florida Mortgage and the related interest rate swap was terminated on this date (see Note 6 and Note 18(b)). The Company will lease approximately 18,000 square feet of office and warehouse space in the building from the buyer for a period of five years .

Redeemable Non-Controlling In_2

Redeemable Non-Controlling Interest (Tables)	6 Months Ended
Redeemable Non-Controlling Interest (Tables)	Aug. 31, 2024
Rollforward of the Redeemable Non-controlling Interest	The following table provides the rollforward of the redeemable non-controlling interest for the six months ended August 31, 2024: Redeemable Non-controlling Interest Balance at February 29, 2024 $ ( 3,203 ) Net loss attributable to non-controlling interest ( 606 ) Comprehensive loss attributable to non-controlling interest ( 104 ) Foreign currency translation ( 128 ) Balance at August 31, 2024 $ ( 4,041 )

Net Income (Loss) Per Common _2

Net Income (Loss) Per Common Share (Tables)	6 Months Ended
Net Income (Loss) Per Common Share (Tables)	Aug. 31, 2024
Net Income Per Common Share [Abstract]
Reconciliation Between Denominator of Basic and Diluted Net Income (Loss) Per Common Share	A reconciliation between the denominator of basic and diluted net income (loss) per common share is as follows: Three months ended Six months ended 2024 2023 2024 2023 Weighted-average common shares outstanding (basic) 23,125,665 23,462,575 23,132,771 23,629,147 Effect of dilutive securities: Restricted stock units, market stock units, and stock grants 33,668 — - - Weighted-average common shares and potential common shares outstanding (diluted) 23,159,333 23,462,575 23,132,771 23,629,147

Investment Securities (Tables)

Investment Securities (Tables)	6 Months Ended
Investment Securities (Tables)	Aug. 31, 2024
Investment Securities [Abstract]
Summary of Investment Securities	As of August 31, 2024, and February 29, 2024, the Company had the following investments: August 31, 2024 Fair Value Investment Securities Marketable Equity Securities Mutual funds $ 398 Total Marketable Equity Securities 398 Total Investment Securities $ 398 February 29, 2024 Fair Value Investment Securities Marketable Equity Securities Mutual funds $ 828 Total Marketable Securities 828 Total Investment Securities $ 828

Fair Value Measurements and D_2

Fair Value Measurements and Derivatives (Tables)	6 Months Ended
Fair Value Measurements and Derivatives (Tables)	Aug. 31, 2024
Fair Value Disclosures [Abstract]
Assets and Liabilities Measured on Recurring Basis	The following table presents financial assets and liabilities measured at fair value on a recurring basis at August 31, 2024: Fair Value Measurements at Total Level 1 Level 2 Level 3 Assets: Cash and money market funds $ 3,661 $ 3,661 $ - $ - Mutual funds 398 398 - - Derivatives designated for hedging 143 - 143 - The following table presents financial assets and liabilities measured at fair value on a recurring basis at February 29, 2024: Fair Value Measurements at Total Level 1 Level 2 Level 3 Assets: Cash and money market funds $ 10,986 $ 10,986 $ - $ - Mutual funds 828 $ 828 $ - $ - Derivatives designated for hedging 263 - 263 -
Fair Value, by Balance Sheet Grouping	The following table discloses the fair value as of August 31, 2024 and February 29, 2024 of the Company’s derivative instruments: Derivative Assets and Liabilities Fair Value Account August 31, 2024 February 29, 2024 Derivative instruments Foreign currency contracts designated as cash flow hedges Prepaid expenses and other current assets $ 68 $ 121 Interest rate swap agreements designated as cash flow hedges Other assets 75 142 Total derivatives $ 143 $ 263
Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss)	Activity related to cash flow hedges recorded during the three and six months ended August 31, 2024 and 2023 was as follows: Three months ended Six months ended August 31, 2024 August 31, 2024 Pretax Gain (Loss) Pretax Loss Pretax Gain (Loss) Pretax Loss Cash flow hedges Foreign currency contracts 1 ( 37 ) 13 ( 68 ) Interest rate swaps $ ( 67 ) $ - ( 67 ) - Three months ended Six months ended August 31, 2023 August 31, 2023 Pretax Gain Pretax Gain (Loss) Pretax Loss Pretax Gain (Loss) Cash flow hedges Foreign currency contracts - - $ - $ - Interest rate swaps 34 - ( 26 ) -

Accumulated Other Comprehensi_2

Accumulated Other Comprehensive (Loss) Income (Tables)	6 Months Ended
Accumulated Other Comprehensive (Loss) Income (Tables)	Aug. 31, 2024
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]
Schedule of Accumulated Other Comprehensive (Loss) Income	The Company’s accumulated other comprehensive (loss) income consists of the following: Foreign Pension plan Derivatives Total Balance at February 29, 2024 $ ( 17,192 ) $ ( 398 ) $ 224 $ ( 17,366 ) Other comprehensive income (loss) before reclassifications 258 ( 8 ) ( 57 ) 193 Reclassified from accumulated other comprehensive loss (gain) - - ( 46 ) ( 46 ) Net current-period other comprehensive loss 258 ( 8 ) ( 103 ) 147 Balance at August 31, 2024 $ ( 16,934 ) $ ( 406 ) $ 121 $ ( 17,219 )

Supplemental Cash Flow Inform_2

Supplemental Cash Flow Information (Tables)	6 Months Ended
Supplemental Cash Flow Information (Tables)	Aug. 31, 2024
Supplemental Cash Flow Information [Abstract]
Schedule of Cash Flow, Supplemental Disclosures	The following is supplemental information relating to the Unaudited Consolidated Statements of Cash Flows: Six months ended 2024 2023 Non-cash investing and financing activities: Recording of redeemable equity $ ( 63 ) $ ( 46 ) Investment in BioCenturion LLC 2,989 - Cancellation of EyeLock LLC ownership put option 9,817 - Reclassification of shareholder receivable to equity 2,578 - Recording of excise tax attributable to treasury stock repurchases 2 - Right of use assets obtained in exchange for operating lease obligations 556 549 Right of use assets obtained in exchange for finance lease obligations - 575 Cash paid for amounts included in the measurement of lease liabilities: Operating cash flows from operating leases $ 610 $ 648 Operating cash flows from finance leases 30 8 Finance cash flows from finance leases 204 169 Cash paid during the period: Interest (excluding bank charges) $ 3,211 $ 2,135 Income taxes (net of refunds) 2,270 910

Accounting for Stock-Based Co_2

Accounting for Stock-Based Compensation (Tables)	6 Months Ended
Accounting for Stock-Based Compensation (Tables)	Aug. 31, 2024
Share-Based Payment Arrangement, Noncash Expense [Abstract]
Schedule of Redeemable Equity Related to Stock Awards and Shares	A rollforward of redeemable equity related to stock awards and shares held by Mr. Lavelle for the six months ended August 31, 2024 is as follows: Redeemable Equity Balance at February 29, 2024 $ 4,110 Stock based compensation expense 63 Balance at August 31, 2024 $ 4,173
Summary of Activity Related to 2024 Plan	The following table presents a summary of the activity related to the 2024 Plan for the six months ended August 31, 2024: Number Weighted Unvested award balance at February 29, 2024 176,312 $ 8.93 Granted 317,907 3.03 Vested ( 100,792 ) 6.17 Vested and settled ( 5,000 ) 10.66 Unvested award balance at August 31, 2024 388,427 $ 4.02

Goodwill and Intangible Assets

Goodwill and Intangible Assets (Tables)	6 Months Ended
Goodwill and Intangible Assets (Tables)	Aug. 31, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Goodwill	The change in goodwill by segment is as follows: Automotive Electronics: Amount Beginning balance at March 1, 2024 $ 3,052 Activity during the period - Balance at August 31, 2024 $ 3,052 Gross carrying value at August 31, 2024 $ 10,425 Accumulated impairment charge ( 7,373 ) Net carrying value at August 31, 2024 $ 3,052 Consumer Electronics: Beginning balance at March 1, 2024 $ 60,879 Foreign currency adjustments 413 Balance at August 31, 2024 $ 61,292 Gross carrying value at August 31, 2024 $ 93,455 Accumulated impairment charge ( 32,163 ) Net carrying value at August 31, 2024 $ 61,292 Total Goodwill, net $ 64,344 The Company's Biometrics segment did no t carry a goodwill balance at August 31, 2024 or February 29, 2024 .
Schedule of Intangible Assets, Excluding Goodwill	At August 31, 2024, intangible assets consisted of the following: Gross Accumulated Total Net Finite-lived intangible assets: Customer relationships $ 54,053 $ 47,678 $ 6,375 Trademarks/Tradenames 20,588 6,219 14,369 Developed technology 4,965 2,979 1,986 Patents 6,735 6,222 513 License 1,400 1,400 - Contracts 1,556 1,556 - Total finite-lived intangible assets $ 89,297 $ 66,054 23,243 Indefinite-lived intangible assets Trademarks 33,389 Total intangible assets, net $ 56,632 At February 29, 2024, intangible assets consisted of the following: Gross Accumulated Total Net Finite-lived intangible assets: Customer relationships $ 53,915 $ 46,037 $ 7,878 Trademarks/Tradenames 20,323 5,031 15,292 Developed technology 18,970 15,743 3,227 Patents 6,736 6,128 608 License 1,400 1,400 - Contracts 1,556 1,556 - Total finite-lived intangible assets $ 102,900 $ 75,895 27,005 Indefinite-lived intangible assets Trademarks 41,761 Total intangible assets, net $ 68,766
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense	The estimated aggregate amortization expense for all amortizable intangibles for August 31 of each of the succeeding years is as follows: Year Amount 2025 $ 5,694 2026 4,306 2027 3,110 2028 2,908 2029 2,866

Equity Investments (Tables)

Equity Investments (Tables)	6 Months Ended
Equity Investments (Tables)	Aug. 31, 2024
Equity Method Investment, Summarized Financial Information [Abstract]
Summary of Assets Contributed	The following summarizes the preliminary allocation of the assets contributed to the joint venture by EyeLock on March 1, 2024 based upon their fair values: March 1, 2024 Assets contributed: Inventory $ 1,839 Accounts receivable, net 46 Property, plant, and equipment 4 Tradenames 1,630 Developed technology 2,460 Total contribution $ 5,979
Equity Method Investments, Summarized Financial Information	The following presents summary financial information for ASA. Such summary financial information has been provided herein based upon the individual significance of ASA to the consolidated financial information of the Company. August 31, 2024 February 29, 2024 Current assets $ 43,390 $ 43,790 Non-current assets 7,386 7,579 Liabilities 8,330 8,609 Members' equity 42,446 42,760 Six months ended 2024 2023 Net sales $ 32,286 $ 42,192 Gross profit 8,638 11,115 Operating income 3,294 5,321 Net income 3,832 5,714

Inventory (Tables)

Inventory (Tables)	6 Months Ended
Inventory (Tables)	Aug. 31, 2024
Inventory Disclosure [Abstract]
Schedule of Inventory, Current	Inventories by major category are as follows: August 31, February 29, Raw materials $ 17,522 $ 21,527 Work in process 577 736 Finished goods 95,154 106,208 Inventory $ 113,253 $ 128,471

Product Warranties and Produc_2

Product Warranties and Product Repair Costs (Tables)	6 Months Ended
Product Warranties and Product Repair Costs (Tables)	Aug. 31, 2024
Payables And Accruals Warranties [Abstract]
Schedule of Product Warranty Liability	The following table provides a summary of the activity with respect to product warranties and product repair costs. The liability for product warranties is included within Accrued expenses and other current liabilities and the reserve for product repair costs is recorded as a reduction of Inventory on the Consolidated Balance Sheets. Three months ended Six months ended 2024 2023 2024 2023 Opening balance $ 6,622 $ 6,953 $ 6,593 $ 6,759 Liabilities for warranties and product repair costs accrued during the period 1,023 723 2,356 2,025 Warranty claims settled and product repair costs expended during the period ( 1,294 ) ( 1,009 ) ( 2,598 ) ( 2,117 ) Ending balance $ 6,351 $ 6,667 $ 6,351 $ 6,667

Financing Arrangements (Tables)

Financing Arrangements (Tables)	6 Months Ended
Financing Arrangements (Tables)	Aug. 31, 2024
Debt Disclosure [Abstract]
Schedule of Debt	The Company has the following financing arrangements: August 31, February 29, Debt Domestic credit facility (a) $ 45,832 $ 63,843 Florida mortgage (b) 5,365 5,615 Euro asset-based lending obligation - VOXX Germany (c) - - Shareholder loan payable (d) 3,970 3,813 Total debt 55,167 73,271 Less: current portion of long-term debt 4,469 500 Long-term debt 50,698 72,771 Less: debt issuance costs 683 890 Total long-term debt, net of debt issuance costs $ 50,015 $ 71,881 (a) Domestic Credit Facility The Company has a senior secured credit facility (the "Credit Facility") with Wells Fargo Bank, N.A. ("Wells Fargo") that provides for a revolving credit facility with committed availability of up to $ 165,000 . The Credit Facility also includes a $ 50,000 sub-limit for letters of credit and a $ 15,000 sub-limit for Swing Loans. The availability under the revolving credit line within the Credit Facility is subject to a borrowing base, which is based on eligible accounts receivable, eligible inventory, certain real estate, and certain intellectual property, subject to reserves as determined by the lender, and is also limited by amounts outstanding under the Florida Mortgage (see Note 18(b)). The availability under the revolving credit line of the Credit Facility was $ 62,275 as of August 31, 2024. All amounts outstanding under the Credit Facility will mature and become due on April 19, 2026 ; however, it is subject to acceleration upon the occurrence of an Event of Default as defined in the Second Amended and Restated Credit Agreement (“the Agreement”). The Company may prepay any amounts outstanding at any time. The commitments under the Credit Facility may be irrevocably reduced at any time, without premium or penalty as set forth in the Agreement. Generally, the Company may designate specific borrowings under the Credit Facility as either Base Rate Loans or SOFR Rate Loans, except that Swing Loans may only be designated as Base Rate Loans. Loans designated as SOFR Rate Loans bear interest at a rate equal to the then applicable SOFR rate plus a range of 1.75 – 2.25 % ( 7.43 % at August 31, 2024 ). Loans designated as Base Rate loans bear interest at a rate equal to the applicable margin for Base Rate Loans plus a range of 0.75 - 1.25 % as defined in the Agreement and shall not be lower than 1.75 % ( 9.50 % at August 31, 2024). Provided that the Company is in a Compliance Period (the period commencing on that day in which Excess Availability is less than 15 % of the Maximum Revolver Amount and ending on a day in which Excess Availability is equal to or greater than 15% for any consecutive 30-day period thereafter) , the Credit Facility requires compliance with a financial covenant calculated as of the last day of each month, consisting of a Fixed Charge Coverage Ratio. The Credit Facility also contains covenants, subject to defined carveouts, that limit the ability of the loan parties and certain of their subsidiaries which are not loan parties to, among other things: (i) incur additional indebtedness; (ii) incur liens; (iii) merge, consolidate or dispose of a substantial portion of their business; (iv) transfer or dispose of assets; (v) change their name, organizational identification number, state or province of organization or organizational identity; (vi) make any material change in their nature of business; (vii) prepay or otherwise acquire indebtedness; (viii) cause any change of control; (ix) make any restricted junior payment, including the declaration of dividends; (x) change their fiscal year or method of accounting; (xi) make advances, loans or investments; (xii) enter into or permit any transaction with an affiliate of any borrower or any of their subsidiaries; (xiii) use proceeds for certain items; (xiv) issue or sell any of their stock; or (xv) consign or sell any of their inventory on certain terms. In addition, if excess availability under the Credit Facility were to fall below certain specified levels, as defined in the Agreement, the lenders would have the right to assume dominion and control over the Company's cash. As of August 31, 2024, the Company was not in a Compliance Period. The obligations under the Credit Facility documents are secured by a general lien on, and security interest in, substantially all of the assets of the borrowers and certain of the guarantors, including accounts receivable, equipment, real estate, general intangibles, and inventory. The Company, as parent, has guaranteed the obligations of its subsidiary borrowers under the Agreement. Charges incurred on the unused portion of the Credit Facility during the three and six months ended August 31, 2024 totaled $ 164 and $ 311 , respectively, compared to $ 199 and $ 405 during the three and six months ended August 31, 2023, respectively. These charges are included within Interest and bank charges on the Unaudited Consolidated Statements of Operations and Comprehensive Income (Loss). The Company has deferred financing costs related to the Credit Facility and previous amendments and modifications of the Credit Facility. Deferred financing costs are included in Long-term debt on the accompanying Consolidated Balance Sheets as a contra-liability balance and are amortized through Interest and bank charges in the Unaudited Consolidated Statements of Operations and Comprehensive Income (Loss) over the term of the Credit Facility, which expires on April 19, 2026 . During the three and six months ended August 31, 2024, the Company amortized $ 92 and $ 184 of these costs, respectively, as compared to $ 89 and $ 176 during the three and six months ended August 31, 2023, respectively. The net unamortized balance of these deferred financing costs as of August 31, 2024 was $ 615 . in accordance with the joint venture agreement (see Note 3). The rate of interest for the shareholder loan is 2.5 % and the loan is secured by a second priority lien on and secured interest in all assets of Onkyo.

Other Income (Expense) (Tables)

Other Income (Expense) (Tables)	6 Months Ended
Other Income (Expense) (Tables)	Aug. 31, 2024
Other Income and Expenses [Abstract]
Schedule of Other Nonoperating Income (Expense)	Other income (expense) is comprised of the following: Three months ended Six months ended 2024 2023 2024 2023 Foreign currency gain (loss), net $ 3,204 $ ( 1,261 ) $ 1,353 $ ( 2,248 ) Interest income 75 16 171 33 Rental income 262 236 522 465 Miscellaneous 301 57 ( 75 ) 97 Total other, net $ 3,842 $ ( 952 ) $ 1,971 $ ( 1,653 )

Lease Obligations (Tables)

Lease Obligations (Tables)	6 Months Ended
Lease Obligations (Tables)	Aug. 31, 2024
Leases [Abstract]
Schedule of Components of Lease Cost	The components of lease cost for the three and six months ended August 31, 2024 and 2023 were as follows: Three months ended Six months ended 2024 2023 2024 2023 Operating lease cost (a) (c) $ 318 $ 338 $ 631 $ 703 Finance lease cost: Amortization of right of use assets (a) 109 100 218 169 Interest on lease liabilities (b) 18 7 30 8 Total finance lease cost $ 127 $ 107 248 $ 177 (a) Recorded within Selling, General and administrative, Engineering and technical support, and Cost of sales on the Unaudited Consolidated Statements of Operations and Comprehensive Income (Loss) . (b) Recorded within Interest and bank charges on the Unaudited Consolidated Statements of Operations and Comprehensive Income (Loss) . (c) Includes immaterial amounts related to variable rent expense.
Schedule of Supplemental Balance Sheet Information Related to Leases	Supplemental balance sheet information related to leases is as follows: August 31, 2024 February 29, 2024 Operating Leases Operating lease, right of use assets $ 2,815 $ 2,577 Total operating lease right of use assets $ 2,815 $ 2,577 Accrued expenses and other current liabilities $ 1,017 $ 782 Operating lease liabilities, less current portion 1,917 1,884 Total operating lease liabilities $ 2,934 $ 2,666 Finance Leases Property, plant, and equipment, gross 3,835 $ 3,835 Accumulated depreciation ( 3,081 ) ( 2,863 ) Total finance lease right of use assets 754 $ 972 Accrued expenses and other current liabilities $ 305 $ 349 Finance lease liabilities, less current portion 484 644 Total finance lease liabilities $ 789 $ 993 Weighted Average Remaining Lease Term Operating leases 4.2 years 4.9 years Finance leases 2.9 years 3.1 years Weighted Average Discount Rate Operating leases 4.74 % 4.12 % Finance leases 7.05 % 8.45 %
Schedule of Maturities of Leases Liabilities	Maturities of lease liabilities on August 31 of each of the succeeding years are as follows: Operating Leases Finance Leases 2025 $ 1,104 366 2026 747 299 2027 381 111 2028 257 111 2029 250 9 Thereafter 431 - Total lease payments 3,170 896 Less imputed interest 236 107 Total $ 2,934 789

Capital Structure (Tables)

Capital Structure (Tables)	6 Months Ended
Capital Structure (Tables)	Aug. 31, 2024
Equity [Abstract]
Schedule of Capital Units	The Company's capital structure is as follows: Shares Authorized Shares Outstanding Security Par August 31, 2024 February 29, 2024 August 31, 2024 February 29, 2024 Voting Liquidation Preferred Stock $ 50.00 50,000 50,000 - - - $ 50 per share Series Preferred Stock $ 0.01 1,500,000 1,500,000 - - - — Class A Common Stock $ 0.01 60,000,000 60,000,000 19,647,196 19,698,562 1 Ratably with Class B Common Stock $ 0.01 10,000,000 10,000,000 2,260,954 2,260,954 10 Ratably with Treasury Stock at cost at cost 4,351,183 4,287,041 N/A N/A N/A

Variable Interest Entity (Table

Variable Interest Entity (Tables) - Variable Interest Entity, Primary Beneficiary [Member]	6 Months Ended
	Aug. 31, 2024
Variable Interest Entity [Line Items]
Summary of Carrying Values of Assets and Liabilities Included in Consolidated Balance Sheets	The following table sets forth the carrying values of assets and liabilities of EyeLock LLC that were included on our Consolidated Balance Sheets as of August 31, 2024 and February 29, 2024: August 31, February 29, Assets (unaudited) Current assets: Cash and cash equivalents $ 4 $ - Accounts receivable, net ( 25 ) 64 Inventory, net - 1,839 Due from GalvanEyes LLC , current - 1,238 Prepaid expenses and other current assets - 58 Total current assets ( 21 ) 3,199 Equity investment 1,625 - Property, plant and equipment, net - 4 Intangible assets, net - 1,514 Due from GalvanEyes LLC , less current portion - 1,340 Other assets - 5 Total assets $ 1,604 $ 6,062 Liabilities and Partners' Deficit Current liabilities: Accounts payable $ 769 $ 759 Interest payable to VOXX 17,416 16,525 Accrued expenses and other current liabilities 107 287 Due to VOXX 69,301 69,377 Total current liabilities 87,593 86,948 Prepaid ownership interest in EyeLock LLC due to GalvanEyes LLC - 9,817 Other long-term liabilities 1,200 1,200 Total liabilities 88,793 97,965 Commitments and contingencies Partners' deficit: Capital 48,496 41,416 Retained losses ( 135,685 ) ( 133,319 ) Total partners' deficit ( 87,189 ) ( 91,903 ) Total liabilities and partners' deficit $ 1,604 $ 6,062
Summary of Revenues and Expenses Included in Consolidated Statements of Operations and Comprehensive Income (Loss)	The following table sets forth the revenues and expenses of EyeLock LLC that were included in our Unaudited Consolidated Statements of Operations and Comprehensive Income (Loss) for the three and six months ended August 31, 2024 and 2023: For the three months For the six months 2024 2023 2024 2023 Net sales - $ 210 $ 8 $ 310 Cost of sales 139 153 139 205 Gross profit ( 139 ) 57 ( 131 ) 105 Operating expenses: Selling ( 10 ) 28 ( 9 ) 217 General and administrative ( 4 ) 449 33 888 Engineering and technical support ( 6 ) 563 ( 19 ) 1,221 Total operating expenses ( 20 ) 1,040 5 2,326 Operating loss ( 119 ) ( 983 ) ( 136 ) ( 2,221 ) Other expense: Interest and bank charges ( 448 ) ( 433 ) ( 899 ) ( 861 ) Equity in loss of equity investee ( 601 ) - ( 1,365 ) - Other, net 397 - 34 - Total other expense, net ( 652 ) ( 433 ) ( 2,230 ) ( 861 ) Loss before income taxes ( 771 ) ( 1,416 ) ( 2,366 ) ( 3,082 ) Income tax expense - - - - Net loss $ ( 771 ) $ ( 1,416 ) $ ( 2,366 ) $ ( 3,082 )

Segment Reporting (Tables)

Segment Reporting (Tables)	6 Months Ended
Segment Reporting (Tables)	Aug. 31, 2024
Segment Reporting [Abstract]
Schedule of Segment Reporting Information by Segments	Segment data for each of the Company's segments is presented below: Automotive Consumer Biometrics (a) Corporate/ Total Three Months Ended August 31, 2024 Net sales $ 26,381 $ 66,058 - $ 49 $ 92,488 Equity in income of equity investees (a) 801 - ( 601 ) - 200 Interest expense and bank charges 359 1,677 448 ( 511 ) 1,973 Depreciation and amortization expense 746 1,475 - 644 2,865 (Loss) income before income taxes (a) (b) ( 1,812 ) 5,933 ( 770 ) 41 3,392 Three Months Ended August 31, 2023 Net sales $ 35,417 $ 78,044 $ 209 $ ( 28 ) $ 113,642 Equity in income of equity investees 1,241 - - - 1,241 Interest expense and bank charges 493 2,002 433 ( 1,355 ) 1,573 Depreciation and amortization expense 818 1,491 70 866 3,245 Loss before income taxes ( 622 ) ( 3,208 ) ( 1,416 ) ( 6,161 ) ( 11,407 ) Six Months Ended August 31, 2024 Net sales $ 54,066 $ 129,976 $ 8 $ 99 $ 184,149 Equity in income (loss) of equity investees (a) 1,916 - ( 1,365 ) - 551 Interest expense and bank charges 770 3,494 899 ( 1,052 ) 4,111 Depreciation and amortization expense 1,489 2,946 - 1,294 5,729 (Loss) income before income taxes (a) (b) ( 3,628 ) 4,609 ( 2,365 ) ( 5,995 ) ( 7,379 ) Six Months Ended August 31, 2023 Net sales $ 73,829 $ 151,374 $ 309 $ 56 $ 225,568 Equity in income of equity investees 2,857 - - - 2,857 Interest expense and bank charges 1,044 4,066 861 ( 2,852 ) 3,119 Depreciation and amortization expense 1,698 2,954 140 1,700 6,492 Loss before income taxes ( 1,900 ) ( 6,967 ) ( 3,082 ) ( 12,484 ) ( 24,433 ) (a) On March 1, 2024, the Company's majority owned subsidiary, EyeLock LLC, contributed assets, including inventory and intangible assets, to a newly formed joint venture, BioCenturion LLC, which will operate a Biometrics business. For the three and six months ended August 31, 2024 , the Company accounted for its investment in BioCenturion LLC as an equity method investment (see Note 12). (b) Included in Income before taxes within the Consumer Electronics segment for the three and six months ended August 31, 2024 is a gain on the sale of a business in the amount of $ 8,300 and a gain on the sale of assets in the amount of $ 2,154 (see Note 2).

Revenue from Contracts with C_2

Revenue from Contracts with Customers (Tables)	6 Months Ended
Revenue from Contracts with Customers (Tables)	Aug. 31, 2024
Revenue from Contract with Customer [Abstract]
Reconciliation of Contract Liabilities	The following table provides a reconciliation of the Company’s contract liabilities as of August 31, 2024: Balance at February 29, 2024 $ 4,419 Subscription payments received 2,777 Revenue recognized ( 3,360 ) Balance at August 31, 2024 $ 3,836
Disaggregation of Revenue	The Company operates in three reportable segments: Automotive Electronics, Consumer Electronics, and Biometrics. ASC 606 requires further disaggregation of an entity’s revenue. In the following table, the Company's net sales are disaggregated by segment and product type for the three and six months ended August 31, 2024 and 2023: Three months ended Six months ended 2024 2023 2024 2023 Automotive Electronics Segment OEM Products $ 11,013 $ 16,252 $ 23,852 $ 36,535 Aftermarket Products 15,368 19,165 30,214 37,294 Total Automotive Segment 26,381 35,417 54,066 73,829 Consumer Electronics Segment Premium Audio Products 49,926 53,199 98,308 100,803 Other Consumer Electronic Products 16,132 24,845 31,668 50,571 Total Consumer Electronics Segment 66,058 78,044 129,976 151,374 Biometrics Segment Biometric Products (a) - 209 8 309 Total Biometrics Segment - 209 8 309 Corporate/Eliminations 49 ( 28 ) 99 56 Total Net Sales $ 92,488 $ 113,642 $ 184,149 $ 225,568 (a) On March 1, 2024, the Company's majority owned subsidiary, EyeLock LLC, contributed assets, including inventory and intangible assets, to a newly formed joint venture, BioCenturion LLC, that will operate a Biometrics business. For the three and six months ended August 31, 2024 , the Company accounted for its investment in BioCenturion LLC as an equity method investment (see Note 13).

Basis of Presentation - Additio

Basis of Presentation - Additional Information (Details) $ in Thousands	3 Months Ended		6 Months Ended
	Aug. 31, 2023 USD ($)	May 31, 2023 USD ($)	Aug. 31, 2024 Segment
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Number of reportable segments \| Segment			3
Net loss attributable to non-controlling interest understated		$ 239
Net loss attributable to non-controlling interest overstated	$ 239
Net loss attributable to VOXX International Corporation and Subsidiaries overstated		$ 239
Net loss attributable to VOXX International Corporation and Subsidiaries understated	$ 239

Dispositions - Additional Infor

Dispositions - Additional Information (Details) - USD ($) $ in Thousands			1 Months Ended	3 Months Ended		6 Months Ended
	Aug. 31, 2024	Aug. 15, 2024	Sep. 30, 2024	Aug. 31, 2024	Aug. 31, 2023	Aug. 31, 2024	Aug. 31, 2023
Dispositions [Line Items]
Gain on sale of business				$ 8,300	$ 0	$ 8,300	$ 0
Gain on sale of assets				2,154	$ 0	2,154	$ 0
PAC [Member]
Dispositions [Line Items]
Total consideration for net of selling expense		$ 3,410
Gain on sale of assets				2,154		2,154
VAC [Member]
Dispositions [Line Items]
Total consideration for net of selling expense	$ 24,542
Gain on sale of business				$ 8,300		$ 8,300
VAC [Member] \| Subsequent Event [Member]
Dispositions [Line Items]
Proceeds from sale of business			$ 24,442
Amount to be received from sale of business			$ 100

Redeemable Non-Controlling In_3

Redeemable Non-Controlling Interest - Additional Information (Details) - Onkyo Home Entertainment Corporation [Member]	Sep. 08, 2021
PAC [Member]
Redeemable Noncontrolling Interest [Line Items]
Business acquisition, percentage of interests acquired	77.20%
Voting interest in joint venture	85.10%
Sharp Corporation [Member]
Redeemable Noncontrolling Interest [Line Items]
Business acquisition, percentage of interests acquired	22.80%
Voting interest in joint venture	14.90%

Redeemable Non-Controlling In_4

Redeemable Non-Controlling Interest - Rollforward of the Redeemable Non-controlling Interest (Details) - USD ($) $ in Thousands	3 Months Ended				6 Months Ended
	Aug. 31, 2024	May 31, 2024	Aug. 31, 2023	May 31, 2023	Aug. 31, 2024
Redeemable Noncontrolling Interest [Line Items]
Balance at Beginning Period		$ (3,203)			$ (3,203)
Net loss attributable to non-controlling interest	$ (320)	(286)	$ (961)	$ (317)
Balance at Ending Period	(4,041)				(4,041)
Onkyo Home Entertainment Corporation [Member]
Redeemable Noncontrolling Interest [Line Items]
Balance at Beginning Period		$ (3,203)			(3,203)
Net loss attributable to non-controlling interest					(606)
Comprehensive loss attributable to non-controlling interest					(104)
Foreign currency translation					(128)
Balance at Ending Period	$ (4,041)				$ (4,041)

Net Income (Loss) Per Common _3

Net Income (Loss) Per Common Share - Reconciliation Between Denominator of Basic and Diluted Net Income (Loss) Per Common Share (Details) - shares	3 Months Ended		6 Months Ended
	Aug. 31, 2024	Aug. 31, 2023	Aug. 31, 2024	Aug. 31, 2023
Net Income Per Common Share [Abstract]
Weighted-average common shares outstanding (basic)	23,125,665	23,462,575	23,132,771	23,629,147
Restricted stock units, market stock units, and stock grants	33,668	0	0	0
Weighted-average common shares and potential common shares outstanding (diluted)	23,159,333	23,462,575	23,132,771	23,629,147

Net Income (Loss) Per Common _4

Net Income (Loss) Per Common Share - Additional Information (Details) - shares	3 Months Ended		6 Months Ended
	Aug. 31, 2024	Aug. 31, 2023	Aug. 31, 2024	Aug. 31, 2023
Net Income Per Common Share [Abstract]
Antidilutive securities excluded from computation of earnings per share, amount	106,862	290,173	264,085	292,877

Investment Securities - Summary

Investment Securities - Summary of Investment Securities (Details) - USD ($) $ in Thousands	Aug. 31, 2024	Feb. 29, 2024
Gain (Loss) on Securities [Line Items]
Marketable Equity Securities	$ 398	$ 828
Investments, Fair Value Disclosure	398	828
Mutual Funds [Member]
Gain (Loss) on Securities [Line Items]
Marketable Equity Securities	$ 398	$ 828

Fair Value Measurements and D_3

Fair Value Measurements and Derivatives - Additional Information (Details)	6 Months Ended
	Aug. 31, 2024 USD ($) Derivative
Derivative Instruments Gain Loss [Line Items]
Derivative, Fixed Interest Rate	3.43%
Amount excluded from assessment of hedge effectiveness	$ 0
Foreign currency contracts terminated \| Derivative	0
Open Forward Foreign Currency Option Contracts [Member]
Derivative Instruments Gain Loss [Line Items]
Current outstanding notional value	$ 20,700,000
Interest Rate Swap [Member]
Derivative Instruments Gain Loss [Line Items]
Current outstanding notional value	$ 5,365,000

Fair Value Measurements and D_4

Fair Value Measurements and Derivatives - Assets and Liabilities Measured on Recurring Basis (Details) - USD ($) $ in Thousands	Aug. 31, 2024	Feb. 29, 2024
Assets:
Cash and money market funds	$ 3,661	$ 10,986
Mutual funds	$ 398	$ 828
Investment, Type [Extensible Enumeration]	Mutual Fund [Member]	Mutual Fund [Member]
Designated as Hedging Instrument [Member]
Assets:
Interest rate swap agreements	$ 143	$ 263
Derivative Asset, Statement of Financial Position [Extensible Enumeration]	Other Assets, Noncurrent	Other Assets, Noncurrent
Level 1 [Member]
Assets:
Cash and money market funds	$ 3,661	$ 10,986
Mutual funds	398	828
Level 1 [Member] \| Designated as Hedging Instrument [Member]
Assets:
Interest rate swap agreements	$ 0	$ 0
Derivative Asset, Statement of Financial Position [Extensible Enumeration]	Other Assets, Noncurrent	Other Assets, Noncurrent
Level 2 [Member]
Assets:
Cash and money market funds	$ 0	$ 0
Mutual funds	0	0
Level 2 [Member] \| Designated as Hedging Instrument [Member]
Assets:
Interest rate swap agreements	$ 143	$ 263
Derivative Asset, Statement of Financial Position [Extensible Enumeration]	Other Assets, Noncurrent	Other Assets, Noncurrent
Level 3 [Member]
Assets:
Cash and money market funds	$ 0	$ 0
Mutual funds	0	0
Level 3 [Member] \| Designated as Hedging Instrument [Member]
Assets:
Interest rate swap agreements	$ 0	$ 0
Derivative Asset, Statement of Financial Position [Extensible Enumeration]	Other Assets, Noncurrent	Other Assets, Noncurrent

Fair Value Measurements and D_5

Fair Value Measurements and Derivatives - Fair Value, by Balance Sheet Grouping (Details) - USD ($) $ in Thousands	Aug. 31, 2024	Feb. 29, 2024
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]
Prepaid expenses and other current assets	$ 15,743	$ 20,820
Derivative Assets and Liabilities	143	263
Designated as Hedging Instrument [Member] \| Foreign Exchange Forward [Member]
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]
Prepaid expenses and other current assets	68	121
Designated as Hedging Instrument [Member] \| Interest Rate Swap [Member]
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]
Other assets	$ 75	$ 142

Fair Value Measurements and D_6

Fair Value Measurements and Derivatives - Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss) (Details) - Designated as Hedging Instrument [Member] - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Aug. 31, 2024	Aug. 31, 2023	Aug. 31, 2024	Aug. 31, 2023
Foreign Exchange Forward [Member]
Derivative Instruments Gain Loss [Line Items]
Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, before Tax	$ 1	$ 0	$ 13	$ 0
Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net	$ (37)	$ 0	$ (68)	$ 0
Derivative Instrument, Gain (Loss) Reclassified from AOCI into Income, Effective Portion, Statement of Income or Comprehensive Income [Extensible Enumeration]	Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax	Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax	Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax	Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax
Interest Rate Swap [Member]
Derivative Instruments Gain Loss [Line Items]
Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, before Tax	$ (67)	$ 34	$ (67)	$ (26)
Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net	$ 0	$ 0	$ 0	$ 0

Accumulated Other Comprehensi_3

Accumulated Other Comprehensive (Loss) Income - Schedule of Accumulated Other Comprehensive (Loss) Income (Details) - USD ($) $ in Thousands	3 Months Ended				6 Months Ended
	Aug. 31, 2024	May 31, 2024	Aug. 31, 2023	May 31, 2023	Aug. 31, 2024	Aug. 31, 2023
Accumulated Other Comprehensive Income Loss [Line Items]
Stockholders equity, beginning of period	$ 252,436	$ 255,393	$ 290,628	$ 305,716	$ 255,393	$ 305,716
Other comprehensive (loss) income, net of tax	(435)	582	849	177	147	1,026
Stockholders equity, end of period	254,028	252,436	277,186	290,628	254,028	277,186
Foreign Currency Translation Losses [Member]
Accumulated Other Comprehensive Income Loss [Line Items]
Stockholders equity, beginning of period		(17,192)			(17,192)
Other comprehensive income (loss) before reclassifications					258
Reclassified from accumulated other comprehensive loss (gain)					0
Other comprehensive (loss) income, net of tax					258
Stockholders equity, end of period	(16,934)				(16,934)
Pension Plan Adjustments, Net of Tax [Member]
Accumulated Other Comprehensive Income Loss [Line Items]
Stockholders equity, beginning of period		(398)			(398)
Other comprehensive income (loss) before reclassifications					(8)
Reclassified from accumulated other comprehensive loss (gain)					0
Other comprehensive (loss) income, net of tax					(8)
Stockholders equity, end of period	(406)				(406)
Derivatives Designated in a Hedging Relationship, Net of Tax [Member]
Accumulated Other Comprehensive Income Loss [Line Items]
Stockholders equity, beginning of period		224			224
Other comprehensive income (loss) before reclassifications					(57)
Reclassified from accumulated other comprehensive loss (gain)					(46)
Other comprehensive (loss) income, net of tax					(103)
Stockholders equity, end of period	121				121
Accumulated Other Comprehensive Income (Loss) [Member]
Accumulated Other Comprehensive Income Loss [Line Items]
Stockholders equity, beginning of period	(16,784)	(17,366)	(18,503)	(18,680)	(17,366)	(18,680)
Other comprehensive income (loss) before reclassifications					193
Reclassified from accumulated other comprehensive loss (gain)					(46)
Other comprehensive (loss) income, net of tax	(435)	582	849	177	147
Stockholders equity, end of period	$ (17,219)	$ (16,784)	$ (17,654)	$ (18,503)	$ (17,219)	$ (17,654)

Accumulated Other Comprehensi_4

Accumulated Other Comprehensive (Loss) Income - Additional Information (Details) - USD ($) $ in Thousands	3 Months Ended	6 Months Ended
	Aug. 31, 2024	Aug. 31, 2024
Accumulated Other Comprehensive Income Loss [Line Items]
Other comprehensive (loss) income, net of tax impact related to derivatives designated in hedging relationship	$ (12)	$ (18)
Foreign Currency Translation Gains [Member]
Accumulated Other Comprehensive Income Loss [Line Items]
Other comprehensive (loss) income before reclassifications		258
Foreign Currency Translation Gains [Member] \| Intercompany Transactions Of Long Term Investment Nature [Member]
Accumulated Other Comprehensive Income Loss [Line Items]
Other comprehensive (loss) income before reclassifications		(602)
Foreign Currency Translation Gains [Member] \| Translating Financial Statements [Member]
Accumulated Other Comprehensive Income Loss [Line Items]
Other comprehensive (loss) income before reclassifications		$ 860

Supplemental Cash Flow Inform_3

Supplemental Cash Flow Information - Schedule of Cash Flow, Supplemental Disclosures (Details) - USD ($) $ in Thousands	6 Months Ended
	Aug. 31, 2024	Aug. 31, 2023
Supplemental Cash Flow Information [Abstract]
Recording of redeemable equity	$ (63)	$ (46)
Investment in BioCenturion LLC	2,989	0
Cancellation of EyeLock LLC ownership put option	9,817	0
Reclassification of shareholder receivable to equity	2,578	0
Recording of excise tax attributable to treasury stock repurchases	2	0
Right of use assets obtained in exchange for operating lease obligations	556	549
Right of use assets obtained in exchange for finance lease obligations	0	575
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases	610	648
Operating cash flows from finance leases	30	8
Finance cash flows from finance leases	204	169
Cash paid during the period:
Interest (excluding bank charges)	3,211	2,135
Income taxes (net of refunds)	$ 2,270	$ 910

Accounting for Stock-Based Co_3

Accounting for Stock-Based Compensation - Additional Information (Details) - USD ($)				1 Months Ended		3 Months Ended			6 Months Ended
	Sep. 28, 2023	Feb. 06, 2023	Jul. 08, 2019	Aug. 31, 2024	Jul. 31, 2024	Aug. 31, 2024	May 31, 2024	Aug. 31, 2023	Aug. 31, 2024	Aug. 31, 2023
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Stock based compensation expense									$ 558,000	$ 466,000
Annual salary	$ 750,000
Cash equivalent share grant	250,000
Patrick M. Lavelle [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Annual salary and cash bonus			$ 1,000,000
Stock based compensation expense						$ 0		$ 23,000	$ 0	46,000
Grant of market stock units maximum amount			$ 5,000,000
Maximum average stock price of grant market stock units			$ 5.49
Maximum increase amount of market stock units award			$ 5,000,000
Maximum threshold share price increases in value of award			$ 15
Share-Based compensation arrangement by share based payment award grant of market stock units, vesting percentage									20%
Share-based compensation arrangement by share based payment award grant of market stock units vesting amount							$ 1,000,000
Patrick M. Lavelle [Member] \| Common Class A [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Award vesting period			5 years
Allocated share-based compensation expense						46,000			$ 105,000
Beat Kahli [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Annual salary		$ 300,000
Allocated share-based compensation expense						0		57,000	4,000	154,000
Beat Kahli [Member] \| Common Class A [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Share-based Compensation arrangement by share-based payment award, equity instruments other than options, grants in period, weighted average grant date fair value		$ 10.66
Beat Kahli [Member] \| Common Class A [Member] \| Seventh Year [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Additional grant of shares under employment agreement		20,000
Ms. Shelton
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Cash equivalents	$ 100,000
Ms. Shelton \| Common Class A [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Award vesting period			5 years
Allocated share-based compensation expense						18,000			42,000
Restricted Stock [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Employee service share-based compensation, nonvested awards, total compensation cost not yet recognized				$ 1,270,000		1,270,000			1,270,000
2024 Plan [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Allocated share-based compensation expense						$ 412,000		$ 208,000	$ 558,000	$ 466,000
2024 Plan [Member] \| Restricted Stock Units [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Share-based compensation arrangement by share-based payment award, expiration period					3 years
Share-based payment award vesting age of employee					65 years
Share-based Compensation arrangement by share-based payment award, equity instruments other than options, grants in period, weighted average grant date fair value									$ 3.03
Stock grants vested									100,792
Vested and unsettled awards, weighted average fair value									$ 6.17
2024 Plan [Member] \| Restricted Stock Units [Member] \| Employees [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Stock issued during period, shares, restricted stock award, gross				267,924	49,983
Share-based Compensation arrangement by share-based payment award, equity instruments other than options, grants in period, weighted average grant date fair value				$ 3.12	$ 2.56
2024 Plan [Member] \| Restricted Stock Units [Member] \| Minimum [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Share-based payment award vesting required service period					10 years
2024 Plan [Member] \| Unsettled Stock Grants and RSU Awards [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Stock grants vested									706,087
Vested and unsettled awards, weighted average fair value									$ 6.93
2012 Equity Incentive Plan [Member] \| Patrick M. Lavelle [Member] \| Common Class A [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Grant of initial shares under employment agreement			200,000
2012 Equity Incentive Plan [Member] \| Patrick M. Lavelle [Member] \| Common Class A [Member] \| March 1, 2021 [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Additional grant of shares under employment agreement			100,000
2012 Equity Incentive Plan [Member] \| Patrick M. Lavelle [Member] \| Common Class A [Member] \| March 1, 2020 [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Additional grant of shares under employment agreement			100,000
2012 Equity Incentive Plan [Member] \| Patrick M. Lavelle [Member] \| Common Class A [Member] \| March 1, 2022 [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Additional grant of shares under employment agreement			100,000

Accounting for Stock-Based Co_4

Accounting for Stock-Based Compensation - Schedule of Redeemable Equity Related to Stock Awards and Shares (Details) - USD ($) $ in Thousands	3 Months Ended				6 Months Ended
	Aug. 31, 2024	May 31, 2024	Aug. 31, 2023	May 31, 2023	Aug. 31, 2024
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Stockholders equity, beginning of period	$ 252,436	$ 255,393	$ 290,628	$ 305,716	$ 255,393
Stock-based compensation expense	373	62	185	235
Stockholders equity, end of period	254,028	252,436	$ 277,186	$ 290,628	254,028
Patrick M. Lavelle [Member] \| Redeemable Equity [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Stockholders equity, beginning of period		$ 4,110			4,110
Stock-based compensation expense					63
Stockholders equity, end of period	$ 4,173				$ 4,173

Accounting for Stock-Based Co_5

Accounting for Stock-Based Compensation - Summary of Activity Related to 2024 Plan (Details) - 2024 Plan [Member] - Restricted Stock Units [Member]	6 Months Ended
	Aug. 31, 2024 $ / shares shares
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Unvested Number of share, Beginning balance \| shares	176,312
Granted \| shares	317,907
Vested \| shares	(100,792)
Vested and settled \| shares	(5,000)
Unvested Number of share, Ending balance \| shares	388,427
Weighted Average Grant Date Fair Value, Beginning balance \| $ / shares	$ 8.93
Weighted Average Grant Date Fair Value, Granted \| $ / shares	3.03
Weighted Average Grant Date Fair Value, Vested \| $ / shares	6.17
Weighted Average Grant Date Fair Value, Vested and settled \| $ / shares	10.66
Weighted Average Grant Date Fair Value, Ending balance \| $ / shares	$ 4.02

Supply Chain Financing - Additi

Supply Chain Financing - Additional Information (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Aug. 31, 2024	Aug. 31, 2023	Aug. 31, 2024	Aug. 31, 2023
Supply Chain Financing [Abstract]
Proceeds from sale of continuing operations	$ 22,024	$ 28,278	$ 41,207	$ 55,633

Research and Development - Addi

Research and Development - Additional Information (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Aug. 31, 2024	Aug. 31, 2023	Aug. 31, 2024	Aug. 31, 2023
Research and Development [Abstract]
Research and development expense	$ 1,235	$ 2,079	$ 2,606	$ 4,455

Goodwill and Intangible Asset_2

Goodwill and Intangible Assets - Schedule of Goodwill (Details) $ in Thousands	6 Months Ended
	Aug. 31, 2024 USD ($)
Goodwill [Line Items]
Goodwill	$ 63,931
Goodwill	64,344
Automotive Electronics [Member]
Goodwill [Line Items]
Goodwill	3,052
Activity during the period	0
Goodwill	3,052
Goodwill, Gross	10,425
Goodwill, Impaired, Accumulated Impairment Loss	(7,373)
Consumer Electronics [Member]
Goodwill [Line Items]
Goodwill	60,879
Goodwill, Foreign currency adjustments	413
Goodwill	61,292
Goodwill, Gross	93,455
Goodwill, Impaired, Accumulated Impairment Loss	$ (32,163)

Goodwill and Intangible Asset_3

Goodwill and Intangible Assets - Additional Information (Details) - USD ($)	3 Months Ended		6 Months Ended
	Aug. 31, 2024	Aug. 31, 2023	Aug. 31, 2024	Aug. 31, 2023	Feb. 29, 2024
Goodwill and Intangible Assets [Line Items]
Goodwill	$ 64,344,000		$ 64,344,000		$ 63,931,000
Amortization of Intangible Assets	1,573,000	$ 1,640,000	3,153,000	$ 3,320,000
Biometrics [Member]
Goodwill and Intangible Assets [Line Items]
Goodwill	$ 0		$ 0		$ 0

Goodwill and Intangible Asset_4

Goodwill and Intangible Assets - Schedule of Intangible Assets, Excluding Goodwill (Details) - USD ($) $ in Thousands	Aug. 31, 2024	Feb. 29, 2024
Goodwill and Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Gross	$ 89,297	$ 102,900
Finite-Lived Intangible Assets, Accumulated Amortization	66,054	75,895
Finite-Lived Intangible Assets, Net	23,243	27,005
Intangible assets, net	56,632	68,766
Trademarks [Member]
Goodwill and Intangible Assets [Line Items]
Indefinite-lived Intangible Assets (Excluding Goodwill)	33,389	41,761
Customer Relationships [Member]
Goodwill and Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Gross	54,053	53,915
Finite-Lived Intangible Assets, Accumulated Amortization	47,678	46,037
Finite-Lived Intangible Assets, Net	6,375	7,878
Trademarks/Tradenames [Member]
Goodwill and Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Gross	20,588	20,323
Finite-Lived Intangible Assets, Accumulated Amortization	6,219	5,031
Finite-Lived Intangible Assets, Net	14,369	15,292
Developed Technology [Member]
Goodwill and Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Gross	4,965	18,970
Finite-Lived Intangible Assets, Accumulated Amortization	2,979	15,743
Finite-Lived Intangible Assets, Net	1,986	3,227
Patents [Member]
Goodwill and Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Gross	6,735	6,736
Finite-Lived Intangible Assets, Accumulated Amortization	6,222	6,128
Finite-Lived Intangible Assets, Net	513	608
License [Member]
Goodwill and Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Gross	1,400	1,400
Finite-Lived Intangible Assets, Accumulated Amortization	1,400	1,400
Finite-Lived Intangible Assets, Net	0	0
Contracts [Member]
Goodwill and Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Gross	1,556	1,556
Finite-Lived Intangible Assets, Accumulated Amortization	1,556	1,556
Finite-Lived Intangible Assets, Net	$ 0	$ 0

Goodwill and Intangible Asset_5

Goodwill and Intangible Assets - Schedule of Finite-Lived Intangible Assets, Future Amortization Expense (Details) $ in Thousands	Aug. 31, 2024 USD ($)
Goodwill and Intangible Assets Disclosure [Abstract]
2025	$ 5,694
2026	4,306
2027	3,110
2028	2,908
2029	$ 2,866

Equity Investments - Additional

Equity Investments - Additional Information (Details) - USD ($) $ in Thousands	3 Months Ended			6 Months Ended
	Aug. 31, 2024		Aug. 31, 2023	Aug. 31, 2024		Aug. 31, 2023	Mar. 01, 2024	Feb. 29, 2024
Schedule of Equity Method Investments [Line Items]
Assets	$ 421,164			$ 421,164				$ 444,006
Income (loss) from equity method investments	200	[1]	$ 1,241	551	[1]	$ 2,857
Equity method investment	22,848			$ 22,848				$ 21,380
Loss on contribution of assets to joint venture	$ (413)
EyeLock [Member]
Schedule of Equity Method Investments [Line Items]
Assets							$ 3,403
ASA Electronics, LLC [Member]
Schedule of Equity Method Investments [Line Items]
Equity method investment, ownership percentage	50%			50%				50%
Income (loss) from equity method investments	$ 801		$ 1,241	$ 1,916		$ 2,857
Equity method investment	21,223			21,223
BioCenturion LLC [Member]
Schedule of Equity Method Investments [Line Items]
Equity method investment, ownership percentage							50%
Initial fair value	2,989			2,989
BioCenturion LLC [Member] \| EyeLock [Member]
Schedule of Equity Method Investments [Line Items]
Income (loss) from equity method investments	(601)			(1,365)
Equity method investment	$ 1,625			$ 1,625
Allocation of profit and loss of joint venture percentage	77.80%			77.80%
Joint Venture Membership Interest				50%
Loss on contribution of assets to joint venture				$ (413)
BioCenturion LLC [Member] \| GalvanEyes [Member]
Schedule of Equity Method Investments [Line Items]
Allocation of profit and loss of joint venture percentage	22.20%			22.20%
Joint Venture Membership Interest				50%
BioCenturion LLC [Member] \| Eyelock And Galvaneyes [Member]
Schedule of Equity Method Investments [Line Items]
Deemed initial capital contribution amount	$ 45,000			$ 45,000
Joint Venture Membership Interest				50%

[1] On March 1, 2024, the Company's majority owned subsidiary, EyeLock LLC, contributed assets, including inventory and intangible assets, to a newly formed joint venture, BioCenturion LLC, which will operate a Biometrics business. For the three and six months ended August 31, 2024 , the Company accounted for its investment in BioCenturion LLC as an equity method investment (see Note 12).

Equity Investments - Summary of

Equity Investments - Summary of Assets Contributed (Details) - USD ($) $ in Thousands	Aug. 31, 2024	Mar. 01, 2024	Feb. 29, 2024
Schedule of Equity Method Investments [Line Items]
Inventory	$ 113,253		$ 128,471
Property, plant, and equipment	$ 44,201		$ 45,070
EyeLock [Member]
Schedule of Equity Method Investments [Line Items]
Inventory		$ 1,839
Accounts receivable, net		46
Property, plant, and equipment		4
Tradenames		1,630
Developed technology		2,460
Total contribution		$ 5,979

Equity Investments - Equity Met

Equity Investments - Equity Method Investments, Summarized Financial Information (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Aug. 31, 2024	Aug. 31, 2023	Aug. 31, 2024	Aug. 31, 2023	May 31, 2024	Feb. 29, 2024	May 31, 2023	Feb. 28, 2023
Schedule of Equity Method Investments [Line Items]
Equity Method Investment, Summarized Financial Information, Current Assets	$ 226,944		$ 226,944			$ 235,868
Equity Method Investment, Summarized Financial Information, Current Liabilities	108,004		108,004			96,983
Equity Method Investment Summarized Financial Information, Equity	254,028	$ 277,186	254,028	$ 277,186	$ 252,436	255,393	$ 290,628	$ 305,716
Equity Method Investment, Summarized Financial Information, Gross Profit (Loss)	22,692	28,625	48,101	56,205
Equity Method Investment, Summarized Financial Information, Net Income (Loss)	1,792	$ (12,577)	(8,385)	(24,282)
ASA Electronics, LLC [Member]
Schedule of Equity Method Investments [Line Items]
Equity Method Investment, Summarized Financial Information, Current Assets	43,390		43,390			43,790
Equity Method Investment, Summarized Financial Information, Noncurrent Assets	7,386		7,386			7,579
Equity Method Investment, Summarized Financial Information, Current Liabilities	8,330		8,330			8,609
Equity Method Investment Summarized Financial Information, Equity	$ 42,446		42,446			$ 42,760
Equity Method Investment, Summarized Financial Information, Revenue			32,286	42,192
Equity Method Investment, Summarized Financial Information, Gross Profit (Loss)			8,638	11,115
Equity Method Investment, Summarized Financial Information, Income (Loss) from Continuing Operations			3,294	5,321
Equity Method Investment, Summarized Financial Information, Net Income (Loss)			$ 3,832	$ 5,714

Income Taxes - Additional Infor

Income Taxes - Additional Information (Details) - USD ($) $ in Thousands	3 Months Ended			6 Months Ended
	Aug. 31, 2024		Aug. 31, 2023	Aug. 31, 2024		Aug. 31, 2023	Feb. 29, 2024
Income Taxes [Line Items]
Income tax provision (benefit)	$ 1,600		$ 1,170	$ 1,006		$ (151)
Unrecognized tax benefits, period increase (decrease)			$ 115			$ 317
Effective income tax rate, continuing operations	47.20%		10.30%	13.60%		0.60%
Income (loss) from continuing operations before income taxes, noncontrolling interest	$ 3,392	[1],[2]	$ (11,407)	$ (7,379)	[1],[2]	$ (24,433)
Effective income tax rate reconciliation, at federal statutory income tax rate, percent	21%		21%	21%		21%
Liability for uncertainty in income taxes, noncurrent	$ 721			$ 721			$ 809
Canada and Australia [Member]
Income Taxes [Line Items]
Unrecognized tax benefits, period increase (decrease)	$ 1,265			$ 1,158

[1] Included in Income before taxes within the Consumer Electronics segment for the three and six months ended August 31, 2024 is a gain on the sale of a business in the amount of $ 8,300 and a gain on the sale of assets in the amount of $ 2,154 (see Note 2). On March 1, 2024, the Company's majority owned subsidiary, EyeLock LLC, contributed assets, including inventory and intangible assets, to a newly formed joint venture, BioCenturion LLC, which will operate a Biometrics business. For the three and six months ended August 31, 2024 , the Company accounted for its investment in BioCenturion LLC as an equity method investment (see Note 12).

Inventory - Schedule of Invento

Inventory - Schedule of Inventory, Current (Details) - USD ($) $ in Thousands	Aug. 31, 2024	Feb. 29, 2024
Inventory Disclosure [Abstract]
Raw materials	$ 17,522	$ 21,527
Work in process	577	736
Finished goods	95,154	106,208
Inventory	$ 113,253	$ 128,471

Product Warranties and Produc_3

Product Warranties and Product Repair Costs - Schedule of Product Warranty Liability (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Aug. 31, 2024	Aug. 31, 2023	Aug. 31, 2024	Aug. 31, 2023
Payables And Accruals Warranties [Abstract]
Opening balance	$ 6,622	$ 6,953	$ 6,593	$ 6,759
Liabilities for warranties accrued during the period	1,023	723	2,356	2,025
Warranty claims settled during the period	(1,294)	(1,009)	(2,598)	(2,117)
Ending balance	$ 6,351	$ 6,667	$ 6,351	$ 6,667

Restructuring Expenses (Additio

Restructuring Expenses (Additional Information) (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Aug. 31, 2024	Aug. 31, 2023	Aug. 31, 2024	Aug. 31, 2023
Restructuring Cost and Reserve [Line Items]
Restructuring expenses	$ 2,098	$ 2,008	$ 2,329	$ 2,067
Restructuring reserve	1,375		1,375
Corporate [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring expenses		177		177
Automotive Electronics [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring expenses	156	726	393	785
Consumer Electronics [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring expenses	$ 1,943	1,077	$ 1,935	1,077
Biometrics [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring expenses		$ 27		$ 27

Financing Arrangements - Schedu

Financing Arrangements - Schedule of Debt (Details) - USD ($) $ in Thousands		Aug. 31, 2024	Feb. 29, 2024
Debt, Long-term and Short-term, Combined Amount		$ 55,167	$ 73,271
Less: current portion of long-term debt		4,469	500
Long-term debt		50,698	72,771
Less: debt issuance costs		683	890
Total long-term debt, net of debt issuance costs		50,015	71,881
Revolving Credit Facility [Member]
Debt, Long-term and Short-term, Combined Amount	[1]	45,832	63,843
Shareholder Loan Payable [Member]
Debt, Long-term and Short-term, Combined Amount	[2]	3,970	3,813
Mortgages [Member]
Debt, Long-term and Short-term, Combined Amount	[3]	5,365	5,615
Less: debt issuance costs		68
Audiovox Germany [Member] \| Foreign Line of Credit [Member]
Debt, Long-term and Short-term, Combined Amount	[4]	$ 0	$ 0

[1] Domestic Credit Facility The Company has a senior secured credit facility (the "Credit Facility") with Wells Fargo Bank, N.A. ("Wells Fargo") that provides for a revolving credit facility with committed availability of up to $ 165,000 . The Credit Facility also includes a $ 50,000 sub-limit for letters of credit and a $ 15,000 sub-limit for Swing Loans. The availability under the revolving credit line within the Credit Facility is subject to a borrowing base, which is based on eligible accounts receivable, eligible inventory, certain real estate, and certain intellectual property, subject to reserves as determined by the lender, and is also limited by amounts outstanding under the Florida Mortgage (see Note 18(b)). The availability under the revolving credit line of the Credit Facility was $ 62,275 as of August 31, 2024. All amounts outstanding under the Credit Facility will mature and become due on April 19, 2026 ; however, it is subject to acceleration upon the occurrence of an Event of Default as defined in the Second Amended and Restated Credit Agreement (“the Agreement”). The Company may prepay any amounts outstanding at any time. The commitments under the Credit Facility may be irrevocably reduced at any time, without premium or penalty as set forth in the Agreement. Generally, the Company may designate specific borrowings under the Credit Facility as either Base Rate Loans or SOFR Rate Loans, except that Swing Loans may only be designated as Base Rate Loans. Loans designated as SOFR Rate Loans bear interest at a rate equal to the then applicable SOFR rate plus a range of 1.75 – 2.25 % ( 7.43 % at August 31, 2024 ). Loans designated as Base Rate loans bear interest at a rate equal to the applicable margin for Base Rate Loans plus a range of 0.75 - 1.25 % as defined in the Agreement and shall not be lower than 1.75 % ( 9.50 % at August 31, 2024). Provided that the Company is in a Compliance Period (the period commencing on that day in which Excess Availability is less than 15 % of the Maximum Revolver Amount and ending on a day in which Excess Availability is equal to or greater than 15% for any consecutive 30-day period thereafter) , the Credit Facility requires compliance with a financial covenant calculated as of the last day of each month, consisting of a Fixed Charge Coverage Ratio. The Credit Facility also contains covenants, subject to defined carveouts, that limit the ability of the loan parties and certain of their subsidiaries which are not loan parties to, among other things: (i) incur additional indebtedness; (ii) incur liens; (iii) merge, consolidate or dispose of a substantial portion of their business; (iv) transfer or dispose of assets; (v) change their name, organizational identification number, state or province of organization or organizational identity; (vi) make any material change in their nature of business; (vii) prepay or otherwise acquire indebtedness; (viii) cause any change of control; (ix) make any restricted junior payment, including the declaration of dividends; (x) change their fiscal year or method of accounting; (xi) make advances, loans or investments; (xii) enter into or permit any transaction with an affiliate of any borrower or any of their subsidiaries; (xiii) use proceeds for certain items; (xiv) issue or sell any of their stock; or (xv) consign or sell any of their inventory on certain terms. In addition, if excess availability under the Credit Facility were to fall below certain specified levels, as defined in the Agreement, the lenders would have the right to assume dominion and control over the Company's cash. As of August 31, 2024, the Company was not in a Compliance Period. The obligations under the Credit Facility documents are secured by a general lien on, and security interest in, substantially all of the assets of the borrowers and certain of the guarantors, including accounts receivable, equipment, real estate, general intangibles, and inventory. The Company, as parent, has guaranteed the obligations of its subsidiary borrowers under the Agreement. Charges incurred on the unused portion of the Credit Facility during the three and six months ended August 31, 2024 totaled $ 164 and $ 311 , respectively, compared to $ 199 and $ 405 during the three and six months ended August 31, 2023, respectively. These charges are included within Interest and bank charges on the Unaudited Consolidated Statements of Operations and Comprehensive Income (Loss). The Company has deferred financing costs related to the Credit Facility and previous amendments and modifications of the Credit Facility. Deferred financing costs are included in Long-term debt on the accompanying Consolidated Balance Sheets as a contra-liability balance and are amortized through Interest and bank charges in the Unaudited Consolidated Statements of Operations and Comprehensive Income (Loss) over the term of the Credit Facility, which expires on April 19, 2026 . During the three and six months ended August 31, 2024, the Company amortized $ 92 and $ 184 of these costs, respectively, as compared to $ 89 and $ 176 during the three and six months ended August 31, 2023, respectively. The net unamortized balance of these deferred financing costs as of August 31, 2024 was $ 615 . (b) Florida Mortgage On July 6, 2015, VOXX HQ LLC, the Company’s wholly owned subsidiary, closed on a $ 9,995 industrial development revenue tax exempt bond under a loan agreement in favor of the Orange County Industrial Development Authority (the “Authority”) to finance the construction of the Company's manufacturing facility and executive offices in Lake Nona, Florida. Wells Fargo Bank, N.A. ("Wells Fargo") was the purchaser of the bond and U.S. Bank National Association is the trustee under an Indenture of Trust with the Authority. Voxx borrowed the proceeds of the bond purchase from the Authority during construction as a revolving loan, which converted to a permanent mortgage upon completion of the facility in January 2016 (the "Florida Mortgage"). The Company makes principal and interest payments to Wells Fargo, which began March 1, 2016 and will continue through March of 2026. The Florida Mortgage bears interest at 79 % of the applicable SOFR Rate plus 1.87 % ( 7.19 % at August 31, 2024) and is secured by a first mortgage on the property, a collateral assignment of leases and rents and a guaranty by the Company. The financial covenants of the Florida Mortgage are as defined in the Company’s Credit Facility with Wells Fargo dated April 26, 2016 and amended in April 2021 and February 2023. The Company is in compliance with the financial covenants of the Florida Mortgage, which are as defined in the Company’s Credit Facility with Wells Fargo dated April 26, 2016, as amended (see Note 27). The Company has deferred financing costs related to the Florida Mortgage and a previous amendment to the loan agreement, which are recorded as deferred financing costs and included in Long-term debt as a contra-liability balance on the accompanying Consolidated Balance Sheets and are being amortized through Interest and bank charges in the Unaudited Consolidated Statements of Operations and Comprehensive Income (Loss) over the remaining term of the Florida Mortgage. The Company amortized $ 11 and $ 22 of these costs during the three and six months ended August 31, 2024, respectively, as compared to $ 11 and $ 20 during the three and six months ended August 31, 2023. The net unamortized balance of these deferred financing costs as of August 31, 2024 is $ 68 . The Company has an interest rate swap agreement to hedge interest rate exposure related to the Florida Mortgage. The swap contract has a set fixed rate equal to 3.43 % (see Note 6 and Note 27). (c) Euro Asset-Based Lending Obligation – VOXX Germany Foreign bank obligations include a Euro Asset-Based Lending ("ABL") credit facility, which has a credit limit of € 8,000 for the Company's subsidiary, VOXX Germany, which expires on October 31, 2024. T he rate of interest for the ABL is the three-month Euribor plus 3.55 % ( 7.04 % at August 31, 2024 ). (d) Shareholder Loan Payable In conjunction with the capitalization and funding of the Company’s Onkyo joint venture, which was created in order to execute the acquisition of certain assets of the home audio/video business of OHEC on September 8, 2021, Onkyo entered into a loan agreement with the shareholders of the joint venture. The loan balance outstanding at August 31, 2024 represents the portion of the loan payable to PAC's joint venture partner. The loan balance due to PAC eliminates in consolidation. All amounts outstanding under the loan will mature and become payable ten years from the execution date of the acquisition, which is September 8, 2031. The loan may be prepaid subject to the approval of the board of directors of the joint venture and must be repaid if either the put or call option is exercised Shareholder Loan Payable In conjunction with the capitalization and funding of the Company’s Onkyo joint venture, which was created in order to execute the acquisition of certain assets of the home audio/video business of OHEC on September 8, 2021, Onkyo entered into a loan agreement with the shareholders of the joint venture. The loan balance outstanding at August 31, 2024 represents the portion of the loan payable to PAC's joint venture partner. The loan balance due to PAC eliminates in consolidation. All amounts outstanding under the loan will mature and become payable ten years from the execution date of the acquisition, which is September 8, 2031. The loan may be prepaid subject to the approval of the board of directors of the joint venture and must be repaid if either the put or call option is exercised in accordance with the joint venture agreement (see Note 3). The rate of interest for the shareholder loan is 2.5 % and the loan is secured by a second priority lien on and secured interest in all assets of Onkyo. Florida Mortgage On July 6, 2015, VOXX HQ LLC, the Company’s wholly owned subsidiary, closed on a $ 9,995 industrial development revenue tax exempt bond under a loan agreement in favor of the Orange County Industrial Development Authority (the “Authority”) to finance the construction of the Company's manufacturing facility and executive offices in Lake Nona, Florida. Wells Fargo Bank, N.A. ("Wells Fargo") was the purchaser of the bond and U.S. Bank National Association is the trustee under an Indenture of Trust with the Authority. Voxx borrowed the proceeds of the bond purchase from the Authority during construction as a revolving loan, which converted to a permanent mortgage upon completion of the facility in January 2016 (the "Florida Mortgage"). The Company makes principal and interest payments to Wells Fargo, which began March 1, 2016 and will continue through March of 2026. The Florida Mortgage bears interest at 79 % of the applicable SOFR Rate plus 1.87 % ( 7.19 % at August 31, 2024) and is secured by a first mortgage on the property, a collateral assignment of leases and rents and a guaranty by the Company. The financial covenants of the Florida Mortgage are as defined in the Company’s Credit Facility with Wells Fargo dated April 26, 2016 and amended in April 2021 and February 2023. The Company is in compliance with the financial covenants of the Florida Mortgage, which are as defined in the Company’s Credit Facility with Wells Fargo dated April 26, 2016, as amended (see Note 27). The Company has deferred financing costs related to the Florida Mortgage and a previous amendment to the loan agreement, which are recorded as deferred financing costs and included in Long-term debt as a contra-liability balance on the accompanying Consolidated Balance Sheets and are being amortized through Interest and bank charges in the Unaudited Consolidated Statements of Operations and Comprehensive Income (Loss) over the remaining term of the Florida Mortgage. The Company amortized $ 11 and $ 22 of these costs during the three and six months ended August 31, 2024, respectively, as compared to $ 11 and $ 20 during the three and six months ended August 31, 2023. The net unamortized balance of these deferred financing costs as of August 31, 2024 is $ 68 . The Company has an interest rate swap agreement to hedge interest rate exposure related to the Florida Mortgage. The swap contract has a set fixed rate equal to 3.43 % (see Note 6 and Note 27). Euro Asset-Based Lending Obligation – VOXX Germany Foreign bank obligations include a Euro Asset-Based Lending ("ABL") credit facility, which has a credit limit of € 8,000 for the Company's subsidiary, VOXX Germany, which expires on October 31, 2024. T he rate of interest for the ABL is the three-month Euribor plus 3.55 % ( 7.04 % at August 31, 2024 ).

Financing Arrangements - Sche_2

Financing Arrangements - Schedule of Debt (Parenthetical) (Details) € in Thousands			3 Months Ended		6 Months Ended
	May 01, 2023	Sep. 08, 2021	Aug. 31, 2024 USD ($)	Aug. 31, 2023 USD ($)	Aug. 31, 2024 USD ($)	Aug. 31, 2023 USD ($)	Feb. 29, 2024 USD ($)	Jul. 06, 2015 USD ($)	Oct. 23, 2000 EUR (€)
Line of credit facility, maturity date					Apr. 19, 2026
Percentage of maximum revolver amount					15%
Debt instrument compliance description					Company is in a Compliance Period (the period commencing on that day in which Excess Availability is less than 15% of the Maximum Revolver Amount and ending on a day in which Excess Availability is equal to or greater than 15% for any consecutive 30-day period thereafter)
Line of credit facility, commitment fee amount			$ 164,000	$ 199,000	$ 311,000	$ 405,000
Debt issuance costs, net			$ 683,000		$ 683,000		$ 890,000
Amortization of deferred financing costs				89,000
Industrial revenue bond								$ 9,995,000
Derivative, Fixed Interest Rate			3.43%		3.43%
Sharp Corporation [Member] \| Shareholder Loan Payable [Member] \| Onkyo Home Entertainment Corporation [Member]
Debt instrument, term		10 years
Debt instrument, interest rate		2.50%
Mortgages [Member]
Debt issuance costs, net			$ 68,000		$ 68,000
Amortization of deferred financing costs			$ 11,000	$ 11,000	$ 22,000	20,000
SOFR Rate [Member]
Debt instrument, interest rate at period end			7.43%		7.43%
SOFR Rate [Member] \| Mortgages [Member]
Debt instrument, basis spread on variable rate	1.87%
Debt instrument, interest rate at period end	79%		7.19%		7.19%
SOFR Rate [Member] \| Minimum [Member]
Debt instrument, basis spread on variable rate					1.75%
SOFR Rate [Member] \| Maximum [Member]
Debt instrument, basis spread on variable rate					2.25%
Base Rate [Member]
Debt instrument, interest rate at period end			9.50%		9.50%
Base Rate [Member] \| Minimum [Member]
Debt instrument, basis spread on variable rate					0.75%
Base Rate [Member] \| Maximum [Member]
Debt instrument, basis spread on variable rate					1.25%
Debt instrument, interest rate during period					1.75%
Wells Fargo [Member]
Line of credit facility, remaining borrowing capacity			$ 62,275,000		$ 62,275,000
Wells Fargo [Member] \| Loans [Member]
Line of credit facility, maximum borrowing capacity			15,000,000		$ 15,000,000
Revolving Credit Facility [Member]
Line of credit facility, maturity date					Apr. 19, 2026
Revolving Credit Facility [Member] \| Wells Fargo [Member]
Line of credit facility, current borrowing capacity			165,000,000		$ 165,000,000
Letter of Credit [Member] \| Wells Fargo [Member]
Line of credit facility, maximum borrowing capacity			50,000,000		50,000,000
Line of Credit [Member]
Debt issuance costs, net			615,000		615,000
Amortization of deferred financing costs			$ 92,000		$ 184,000	$ 176,000
Foreign Line of Credit [Member] \| Audiovox Germany [Member]
Line of credit facility, maximum borrowing capacity \| €									€ 8,000
Debt instrument, basis spread on variable rate					3.55%
Debt instrument, interest rate at period end			7.04%		7.04%

Other Income (Expense) - Schedu

Other Income (Expense) - Schedule of Other Nonoperating Income (Expense) (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Aug. 31, 2024	Aug. 31, 2023	Aug. 31, 2024	Aug. 31, 2023
Other Income and Expenses [Abstract]
Foreign currency gain (loss), net	$ 3,204	$ (1,261)	$ 1,353	$ (2,248)
Interest income	75	16	171	33
Rental income	262	236	522	465
Miscellaneous	301	57	(75)	97
Total other, net	$ 3,842	$ (952)	$ 1,971	$ (1,653)

Other Income (Expense) - Additi

Other Income (Expense) - Additional Information (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Aug. 31, 2024	Aug. 31, 2023	Aug. 31, 2024	Aug. 31, 2023
Other Income and Expenses [Abstract]
Foreign currency gain (loss) attributable to re-measurements	$ 1,915	$ (892)	$ 779	$ (1,347)

Lease Obligations - Additional

Lease Obligations - Additional Information (Details) - USD ($)	3 Months Ended		6 Months Ended
	Aug. 31, 2024	Aug. 31, 2023	Aug. 31, 2024	Aug. 31, 2023
Leases [Line Items]
Short term leases	$ 0		$ 0
Other Income (Expense) [Member]
Leases [Line Items]
Rental income	$ 262,000	$ 236,000	$ 522,000	$ 465,000
Minimum [Member]
Leases [Line Items]
Operating and finance leases remaining lease terms			1 year
Maximum [Member]
Leases [Line Items]
Operating and finance leases remaining lease terms			7 years

Lease Obligations - Schedule of

Lease Obligations - Schedule of Components of Lease Cost (Details) - USD ($) $ in Thousands		3 Months Ended		6 Months Ended
		Aug. 31, 2024	Aug. 31, 2023	Aug. 31, 2024	Aug. 31, 2023
Leases [Abstract]
Operating lease cost	[1],[2]	$ 318	$ 338	$ 631	$ 703
Finance lease cost:
Amortization of right of use assets	[2]	109	100	218	169
Interest on lease liabilities	[3]	18	7	30	8
Total finance lease cost		$ 127	$ 107	$ 248	$ 177

[1] Includes immaterial amounts related to variable rent expense. Recorded within Selling, General and administrative, Engineering and technical support, and Cost of sales on the Unaudited Consolidated Statements of Operations and Comprehensive Income (Loss) . Recorded within Interest and bank charges on the Unaudited Consolidated Statements of Operations and Comprehensive Income (Loss) .

Lease Obligations - Schedule _2

Lease Obligations - Schedule of Supplemental Balance Sheet Information Related to Leases (Details) - USD ($) $ in Thousands	Aug. 31, 2024	Feb. 29, 2024
Operating Leases
Operating lease, right of use assets	$ 2,815	$ 2,577
Total operating lease right of use assets	2,815	2,577
Accrued expenses and other current liabilities	1,017	782
Operating lease liabilities, less current portion	1,917	1,884
Total operating lease liabilities	2,934	2,666
Finance Leases
Property, plant, and equipment, gross	3,835	3,835
Accumulated depreciation	(3,081)	(2,863)
Total finance lease right of use assets	$ 754	$ 972
Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]	Property, Plant and Equipment, Net	Property, Plant and Equipment, Net
Accrued expenses and other current liabilities	$ 305	$ 349
Finance lease liabilities, less current portion	484	644
Total finance lease liabilities	$ 789	$ 993
Weighted Average Remaining Lease Term
Operating leases	4 years 2 months 12 days	4 years 10 months 24 days
Finance leases	2 years 10 months 24 days	3 years 1 month 6 days
Weighted Average Discount Rate
Operating leases	4.74%	4.12%
Finance leases	7.05%	8.45%

Lease Obligations - Schedule _3

Lease Obligations - Schedule of Maturities of Leases Liabilities (Details) - USD ($) $ in Thousands	Aug. 31, 2024	Feb. 29, 2024
Operating Leases
2025	$ 1,104
2026	747
2027	381
2028	257
2029	250
Thereafter	431
Total lease payments	3,170
Less imputed interest	236
Total	2,934	$ 2,666
Finance Leases
2025	366
2026	299
2027	111
2028	111
2029	9
Thereafter	0
Total lease payments	896
Less imputed interest	107
Total	$ 789	$ 993

Capital Structure - Schedule of

Capital Structure - Schedule of Capital Units (Details) - $ / shares	6 Months Ended
	Aug. 31, 2024	Feb. 29, 2024
Capital Unit [Line Items]
Treasury stock, shares	4,351,183	4,287,041
Preferred stock, shares outstanding	0	0
Preferred Stock [Member]
Capital Unit [Line Items]
Preferred Stock, Par or Stated Value Per Share	$ 50
Preferred Stock, Shares Authorized	50,000	50,000
Preferred stock, shares outstanding	0	0
Preferred Stock, Voting Rights	-
Preferred Stock, Liquidation Preference Per Share	$ 50
Series A Preferred Stock [Member]
Capital Unit [Line Items]
Preferred Stock, Par or Stated Value Per Share	$ 0.01
Preferred Stock, Shares Authorized	1,500,000	1,500,000
Preferred stock, shares outstanding	0	0
Preferred Stock, Voting Rights	-
Common Class A [Member]
Capital Unit [Line Items]
Common Stock, Par or Stated Value Per Share	$ 0.01	$ 0.01
Common Stock, Shares Authorized	60,000,000	60,000,000
Treasury stock, shares	4,351,183	4,287,041
Common Stock, Shares, Outstanding	19,647,196	19,698,562
Common Stock, Voting Rights	1
Common Class B [Member]
Capital Unit [Line Items]
Common Stock, Par or Stated Value Per Share	$ 0.01	$ 0.01
Common Stock, Shares Authorized	10,000,000	10,000,000
Common Stock, Shares, Outstanding	2,260,954	2,260,954
Common Stock, Voting Rights	10

Capital Structure (Additional I

Capital Structure (Additional Information) (Details) - USD ($) $ in Thousands	3 Months Ended			6 Months Ended
	May 31, 2024	Aug. 31, 2023	May 31, 2023	Aug. 31, 2024	Feb. 29, 2024
Capital Unit [Line Items]
Repurchase of shares of Class A Common Stock	$ 248	$ 2,859	$ 4,113	$ 248
Common Class A [Member]
Capital Unit [Line Items]
Redeemable equity shares outstanding				597,021	577,581
Repurchase of shares of common stock				64,142
Stock repurchase program, number of shares authorized to be repurchased				816,911

Variable Interest Entity - Addi

Variable Interest Entity - Additional Information (Details) - USD ($)			6 Months Ended	12 Months Ended
	Sep. 03, 2024	Apr. 29, 2021	Aug. 31, 2024	Feb. 28, 2019	Feb. 29, 2024
Variable Interest Entity [Line Items]
Notes, loans and financing receivable, net, noncurrent			1.5
Long-term debt, net of debt issuance costs			$ 50,015,000		$ 71,881,000
Distribution agreement liability amount					9,817,000
GalvanEyes [Member]
Variable Interest Entity [Line Items]
Quarterly installment payment due amount receivable under distribution agreement					$ 2,578,000
GalvanEyes [Member] \| Put Arrangement [Member]
Variable Interest Entity [Line Items]
Equity interest percentage based on occurrence of certain events		20%	20%
Arrangement after initial period Term		2 years
EyeLock [Member] \| Exclusive Distribution Agreement [Member]
Variable Interest Entity [Line Items]
Distribution agreement term		3 years
EyeLock [Member] \| Call Arrangement [Member]
Variable Interest Entity [Line Items]
Equity interest percentage based on occurrence of certain events		20%
EyeLock [Member] \| GalvanEyes [Member] \| Exclusive Distribution Agreement [Member]
Variable Interest Entity [Line Items]
Annual fee receivable under distribution agreement subject to certain closing conditions		$ 10,000,000
Annual fee receivable under distribution agreement term		2 years
EyeLock [Member] \| GalvanEyes [Member] \| Joint Venture Agreement [Member]
Variable Interest Entity [Line Items]
Debt Instrument, Frequency of Periodic Payment			eight quarterly
Debt instrument, interest rate			8%
Notes receivable including accrued interest			$ 2,323,000
Quarterly promissory note installment received	$ 352,000
EyeLock [Member] \| GalvanEyes [Member] \| Maximum [Member] \| Exclusive Distribution Agreement [Member]
Variable Interest Entity [Line Items]
Quarterly fee receivable under distribution agreement subject to certain closing conditions		$ 5,000,000
Variable Interest Entity, Primary Beneficiary [Member]
Variable Interest Entity [Line Items]
Debt instrument, interest rate during period			2.50%	10%
Line of credit facility, maximum borrowing capacity			$ 71,200,000
Long-term debt, net of debt issuance costs			$ 69,301,000

Variable Interest Entity - Summ

Variable Interest Entity - Summary of Carrying Values of Assets and Liabilities Included in Consolidated Balance Sheets (Details) - USD ($) $ in Thousands	Aug. 31, 2024	Feb. 29, 2024
Variable Interest Entity [Line Items]
Cash and cash equivalents	$ 3,661	$ 10,986
Accounts receivable, net	64,240	71,066
Receivables from vendors	795	1,192
Prepaid expenses and other current assets	15,743	20,820
Equity investments	22,848	21,380
Property, plant and equipment, net	44,201	45,070
Intangible assets, net	56,632	68,766
Due from GalvanEyes LLC, less current portion	$ 0	$ 1,340
Other Receivable, after Allowance for Credit Loss, Noncurrent, Related Party [Extensible Enumeration]	us-gaap:RelatedPartyMember	us-gaap:RelatedPartyMember
Other assets	$ 2,922	$ 2,794
Total assets	421,164	444,006
Current portion of long-term debt	4,469	500
Total current liabilities	108,004	96,983
Prepaid ownership interest in EyeLock LLC due to GalvanEyes LLC	0	9,817
Other long-term liabilities	2,850	2,170
Total liabilities	167,004	187,706
Commitments and contingencies
Retained earnings	51,415	58,272
Total liabilities, redeemable equity, redeemable non-controlling interest, and stockholders' equity	421,164	444,006
Variable Interest Entity, Primary Beneficiary [Member]
Variable Interest Entity [Line Items]
Cash and cash equivalents	4	0
Accounts receivable, net	(25)	64
Inventory, net	0	1,839
Due from GalvanEyes LLC, current	$ 0	$ 1,238
Other Receivable, after Allowance for Credit Loss, Current, Related Party [Extensible Enumeration]	us-gaap:RelatedPartyMember	us-gaap:RelatedPartyMember
Prepaid expenses and other current assets	$ 0	$ 58
Total current assets	(21)	3,199
Equity investments	1,625	0
Property, plant and equipment, net	0	4
Intangible assets, net	0	1,514
Due from GalvanEyes LLC, less current portion	$ 0	$ 1,340
Other Receivable, after Allowance for Credit Loss, Noncurrent, Related Party [Extensible Enumeration]	us-gaap:RelatedPartyMember	us-gaap:RelatedPartyMember
Other assets	$ 0	$ 5
Total assets	1,604	6,062
Accounts payable	769	759
Interest payable to VOXX	17,416	16,525
Accrued expenses and other current liabilities	107	287
Current portion of long-term debt	69,301	69,377
Total current liabilities	87,593	86,948
Prepaid ownership interest in EyeLock LLC due to GalvanEyes LLC	0	9,817
Other long-term liabilities	1,200	1,200
Total liabilities	88,793	97,965
Commitments and contingencies
Capital	48,496	41,416
Retained earnings	(135,685)	(133,319)
Total partners' deficit	(87,189)	(91,903)
Total liabilities, redeemable equity, redeemable non-controlling interest, and stockholders' equity	$ 1,604	$ 6,062

Variable Interest Entity - Su_2

Variable Interest Entity - Summary of Revenues and Expenses Included in Consolidated Statements of Operations and Comprehensive Income (Loss) (Details) - USD ($) $ in Thousands	3 Months Ended			6 Months Ended
	Aug. 31, 2024		Aug. 31, 2023	Aug. 31, 2024		Aug. 31, 2023
Variable Interest Entity [Line Items]
Net sales	$ 92,488		$ 113,642	$ 184,149		$ 225,568
Cost of sales	69,796		85,017	136,048		169,363
Gross profit	22,692		28,625	48,101		56,205
Engineering and technical support	6,100		7,857	12,344		16,194
Restructuring expenses	2,098		2,008	2,329		2,067
Total operating expenses	31,823		37,136	64,345		76,125
Operating loss	(9,131)		(8,511)	(16,244)		(19,920)
Interest and bank charges	(1,973)		(1,573)	(4,111)		(3,119)
Equity in income (loss) of equity investees	200	[1]	1,241	551	[1]	2,857
Loss on contribution of assets to joint venture	(413)
Other, net	3,842		(952)	1,971		(1,653)
Total other income (expense), net	12,523		(2,896)	8,865		(4,513)
Income (loss) before income taxes	3,392	[1],[2]	(11,407)	(7,379)	[1],[2]	(24,433)
Income tax expense	1,600		1,170	1,006		(151)
Net income (loss)	1,792		(12,577)	(8,385)		(24,282)
Variable Interest Entity, Primary Beneficiary [Member]
Variable Interest Entity [Line Items]
Net sales	0		210	8		310
Cost of sales	139		153	139		205
Gross profit	(139)		57	(131)		105
Selling	(10)		28	(9)		217
General and administrative expense	(4)		449	33		888
Engineering and technical support	(6)		563	(19)		1,221
Total operating expenses	(20)		1,040	5		2,326
Operating loss	(119)		(983)	(136)		(2,221)
Interest and bank charges	(448)		(433)	(899)		(861)
Equity in income (loss) of equity investees	(601)		0	(1,365)		0
Other, net	397		0	34		0
Total other income (expense), net	(652)		(433)	(2,230)		(861)
Income (loss) before income taxes	(771)		(1,416)	(2,366)		(3,082)
Income tax expense	0		0	0		0
Net income (loss)	$ (771)		$ (1,416)	$ (2,366)		$ (3,082)

[1] On March 1, 2024, the Company's majority owned subsidiary, EyeLock LLC, contributed assets, including inventory and intangible assets, to a newly formed joint venture, BioCenturion LLC, which will operate a Biometrics business. For the three and six months ended August 31, 2024 , the Company accounted for its investment in BioCenturion LLC as an equity method investment (see Note 12). Included in Income before taxes within the Consumer Electronics segment for the three and six months ended August 31, 2024 is a gain on the sale of a business in the amount of $ 8,300 and a gain on the sale of assets in the amount of $ 2,154 (see Note 2).

Segment Reporting - Additional

Segment Reporting - Additional Information (Details)	6 Months Ended
Segment Reporting - Additional Information (Details)	Aug. 31, 2024 Segment
Segment Reporting [Abstract]
Number of reportable segments	3
Number of operating segments	3

Segment Reporting - Schedule of

Segment Reporting - Schedule of Segment Reporting Information by Segments (Details) - USD ($) $ in Thousands	3 Months Ended			6 Months Ended
	Aug. 31, 2024		Aug. 31, 2023	Aug. 31, 2024		Aug. 31, 2023
Segment Reporting Information [Line Items]
Net sales	$ 92,488		$ 113,642	$ 184,149		$ 225,568
Equity in income (loss) of equity investees	200	[1]	1,241	551	[1]	2,857
Interest expense and bank charges	1,973		1,573	4,111		3,119
Depreciation and amortization expense	2,865		3,245	5,729		6,492
(Loss) income before income taxes	3,392	[1],[2]	(11,407)	(7,379)	[1],[2]	(24,433)
Operating Segments [Member] \| Automotive Electronics [Member]
Segment Reporting Information [Line Items]
Net sales	26,381		35,417	54,066		73,829
Equity in income (loss) of equity investees	801	[1]	1,241	1,916	[1]	2,857
Interest expense and bank charges	359		493	770		1,044
Depreciation and amortization expense	746		818	1,489		1,698
(Loss) income before income taxes	(1,812)	[1],[2]	(622)	(3,628)	[1],[2]	(1,900)
Operating Segments [Member] \| Consumer Electronics [Member]
Segment Reporting Information [Line Items]
Net sales	66,058		78,044	129,976		151,374
Equity in income (loss) of equity investees	0	[1]	0	0	[1]	0
Interest expense and bank charges	1,677		2,002	3,494		4,066
Depreciation and amortization expense	1,475		1,491	2,946		2,954
(Loss) income before income taxes	5,933	[1],[2]	(3,208)	4,609	[1],[2]	(6,967)
Operating Segments [Member] \| Biometrics [Member]
Segment Reporting Information [Line Items]
Net sales	0		209	8		309
Equity in income (loss) of equity investees	601	[1]	0	(1,365)	[1]	0
Interest expense and bank charges	448		433	899		861
Depreciation and amortization expense	0		70	0		140
(Loss) income before income taxes	(770)	[1],[2]	(1,416)	(2,365)	[1],[2]	(3,082)
Corporate, Non-Segment [Member]
Segment Reporting Information [Line Items]
Net sales	49		(28)	99		56
Equity in income (loss) of equity investees	0	[1]	0	0	[1]	0
Interest expense and bank charges	(511)		(1,355)	(1,052)		(2,852)
Depreciation and amortization expense	644		866	1,294		1,700
(Loss) income before income taxes	$ 41	[1],[2]	$ (6,161)	$ (5,995)	[1],[2]	$ (12,484)

[1] On March 1, 2024, the Company's majority owned subsidiary, EyeLock LLC, contributed assets, including inventory and intangible assets, to a newly formed joint venture, BioCenturion LLC, which will operate a Biometrics business. For the three and six months ended August 31, 2024 , the Company accounted for its investment in BioCenturion LLC as an equity method investment (see Note 12). Included in Income before taxes within the Consumer Electronics segment for the three and six months ended August 31, 2024 is a gain on the sale of a business in the amount of $ 8,300 and a gain on the sale of assets in the amount of $ 2,154 (see Note 2).

Segment Reporting - Schedule _2

Segment Reporting - Schedule of Segment Reporting Information by Segments (Parenthetical) (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Aug. 31, 2024	Aug. 31, 2023	Aug. 31, 2024	Aug. 31, 2023
Segment Reporting Information [Line Items]
Gain on sale of business	$ 8,300	$ 0	$ 8,300	$ 0
Gain on sale of assets	2,154	$ 0	2,154	$ 0
VAC [Member]
Segment Reporting Information [Line Items]
Gain on sale of business	8,300		8,300
VAC [Member] \| Consumer Electronics [Member]
Segment Reporting Information [Line Items]
Gain on sale of business	8,300		8,300
PAC [Member]
Segment Reporting Information [Line Items]
Gain on sale of assets	2,154		2,154
PAC [Member] \| Consumer Electronics [Member]
Segment Reporting Information [Line Items]
Gain on sale of assets	$ 2,154		$ 2,154

Revenue from Contracts with C_3

Revenue from Contracts with Customers - Additional Information (Details) $ in Thousands	6 Months Ended
	Aug. 31, 2024 USD ($) Segment	Feb. 29, 2024 USD ($)
Disaggregation Of Revenue [Line Items]
Contract with customer, right to recover product	$ 995	$ 1,683
Contract with customer, refund liability	1,769	3,648
Contract with customer, liability	$ 3,836	4,419
Number of reportable segments \| Segment	3
Contract liability to be recognized during the next twelve months	$ 3,265	3,810
Contract with customer, Asset	0	$ 0
Telematic Subscription Services [Member] \| Directed LLC and Directed Electronics Canada Inc [Member]
Disaggregation Of Revenue [Line Items]
Contract with customer, liability	3,836
Contract liability to be recognized during the next twelve months	$ 3,265
Minimum [Member]
Disaggregation Of Revenue [Line Items]
Warrant period	30 days
Maximum [Member]
Disaggregation Of Revenue [Line Items]
Warrant period	3 years

Revenue from Contracts with C_4

Revenue from Contracts with Customers - Reconciliation of Contract Liabilities (Details) $ in Thousands	6 Months Ended
	Aug. 31, 2024 USD ($)
Revenue from Contract with Customer [Abstract]
Balance at February 29, 2024	$ 4,419
Subscription payments received	2,777
Revenue recognized	(3,360)
Balance at August 31, 2024	$ 3,836

Revenue from Contracts with C_5

Revenue from Contracts with Customers - Disaggregation of Revenue (Details) - USD ($) $ in Thousands		3 Months Ended		6 Months Ended
		Aug. 31, 2024	Aug. 31, 2023	Aug. 31, 2024	Aug. 31, 2023
Disaggregation Of Revenue [Line Items]
Net sales		$ 92,488	$ 113,642	$ 184,149	$ 225,568
Corporate, Non-Segment [Member]
Disaggregation Of Revenue [Line Items]
Net sales		49	(28)	99	56
Automotive Electronic [Member] \| Operating Segments [Member]
Disaggregation Of Revenue [Line Items]
Net sales		26,381	35,417	54,066	73,829
Automotive Electronic [Member] \| Operating Segments [Member] \| OEM Products [Member]
Disaggregation Of Revenue [Line Items]
Net sales		11,013	16,252	23,852	36,535
Automotive Electronic [Member] \| Operating Segments [Member] \| Aftermarket Products [Member]
Disaggregation Of Revenue [Line Items]
Net sales		15,368	19,165	30,214	37,294
Consumer Electronics [Member] \| Operating Segments [Member]
Disaggregation Of Revenue [Line Items]
Net sales		66,058	78,044	129,976	151,374
Consumer Electronics [Member] \| Operating Segments [Member] \| Premium Audio Products [Member]
Disaggregation Of Revenue [Line Items]
Net sales		49,926	53,199	98,308	100,803
Consumer Electronics [Member] \| Operating Segments [Member] \| Other Consumer Electronic Products [Member]
Disaggregation Of Revenue [Line Items]
Net sales		16,132	24,845	31,668	50,571
Biometrics [Member] \| Operating Segments [Member]
Disaggregation Of Revenue [Line Items]
Net sales		0	209	8	309
Biometrics [Member] \| Operating Segments [Member] \| Biometric Products [Member]
Disaggregation Of Revenue [Line Items]
Net sales	[1]	$ 0	$ 209	$ 8	$ 309

[1] On March 1, 2024, the Company's majority owned subsidiary, EyeLock LLC, contributed assets, including inventory and intangible assets, to a newly formed joint venture, BioCenturion LLC, that will operate a Biometrics business. For the three and six months ended August 31, 2024 , the Company accounted for its investment in BioCenturion LLC as an equity method investment (see Note 13).

Subsequent Event - Additional I

Subsequent Event - Additional Information (Details) - Subsequent Event [Member]	Sep. 24, 2024 USD ($) ft²
Subsequent Event [Line Items]
Purchase Price \| $	$ 20,000
Lease of office space \| ft²	18,000
Lease term	5 years